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ABSTRACT 
Little is known about cofactor catabolism in the literature. Pyridoxamine, 
thiamin, heme and nicotinic acid degradation pathways are the only well-characterized 
catabolic pathways. In 2012 the Begley lab isolated Microbacterium maritypicum G10 
strain, from DSM Nutritional Products, Germany, that can degrade riboflavin (Vitamin 
B2). Subsequent screening with the cosmid library made from the strain has led to the 
identification of the riboflavin catabolic gene cluster. One of the gene cluster products - 
the enzyme riboflavin lyase (RcaE), is a flavoenzyme that catalyzes the oxidative 
degradation of riboflavin to lumichrome and ribose. The enzymes encoded by the other 
genes of the cluster have been predicted by bioinformatics to include a flavokinase 
(RcaA), a flavin reductase (RcaB) and a ribokinase (RcaD). These enzymes have been 
reconstituted individually. The main focus of this work is the detailed mechanistic 
analysis of riboflavin lyase (RcaE). 
Reconstitution of the enzyme RcaE requires reduced FMN as the cofactor with 
riboflavin and oxygen acting as substrates. Thus, RcaE serves as the first example where 
the reduced cofactor FMN catalyzes the breakdown of a second flavin molecule, 
riboflavin. In this degradation, the participation of a superoxide radical, derived from 
reduced FMN reacting with molecular oxygen at the enzyme active site, has been 
established by direct superoxide incorporation experiments. RcaE is a unique enzyme 
that uptakes superoxide directly and utilizes it to degrade the substrate.  
Till date, there is no report in the literature of an enzyme where a superoxide 
radical abstracts a hydrogen atom from the substrate. Based on our results with the 
iii 
radical trap cyclopropylmethylflavin, we propose that the superoxide radical mediates a 
one electron oxidation of the substrate riboflavin, by a hydrogen atom abstraction from 
the C1′ position of riboflavin to form riboflavin-C1′-radical and hydrogen peroxide. The 
riboflavin-C1′-radical in a second one electron oxidation gets converted to riboflavin-C1′-
imine. Based on the LCMS experiments showing 
18
O
 
incorporation into the ribose from
18
O2, we further propose that the resulting imine recombines with the hydrogen peroxide 
at the active site to give riboflavin-C1′-hydroperoxide. Finally, through reduction to 
riboflavin-C1′-hydroxide and subsequent hydrolysis, the riboflavin-C1′-hydroperoxide 
converts to lumichrome and ribose. 
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CHAPTER I 
INTRODUCTION 
1.1 Riboflavin 
Riboflavin (Vitamin B2) (1) (Figure 1) is a water-soluble vitamin found in dairy 
products, meat, and dark-green vegetables .
1
 It was originally isolated from milk in 1879 
and was named lactochrome.
2
 The biologically active forms of riboflavin (1) are flavin 
mononucleotide (FMN) (2) (Figure 1) and flavin adenine dinucleotide (FAD) (3) 
(Figure 1), which participate in a variety of redox reactions in the cell.
3
 Riboflavin (1) 
also forms a part of the glutathione redox cycle which defends the body against 
oxidative stress, specifically against oxidative injury and lipid peroxidation.
4
 Riboflavin 
deficiency in humans, though rare, may cause anemia, skin disorders and preeclampsia 
in pregnant women. Deficiency of 1 also affects the metabolism of Vitamin B6, folate, 
and niacin.
5
 
 
 
 
 
 
 
1.2 Biosynthesis of riboflavin 
Riboflavin (1) is biosynthesized in bacteria, fungi, yeast and plants. Humans lack 
riboflavin biosynthetic genes, hence uptake the vitamin from dietary sources. The 
Figure 1: Structures of riboflavin and its biologically active forms FMN (2) and FAD (3) 
 2 
 
biosynthetic pathway for riboflavin is shown in Figure 2.
6
 The first step in the 
biosynthesis of riboflavin (1) involves a hydrolytic ring cleavage of GTP (4) to form 4,5-
diaminopyrimidine (5) with the release of formate (6). Subsequent conversion of 5 to 5-
amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione (7) is brought about by sequential 
side chain reduction, deamination and dephosphorylation. In fungi the reduction is 
followed by deamination whereas in bacteria deamination occurs first.
7
 In the next step, 
the 7 undergoes condensation with  ribulose-5-phosphate derived 3,4-dihydroxy-2-
butanone-4-phosphate (8) through an intramolecular rearrangement accompanied by the 
loss of C4 to form 6,7-dimethyl-8-ribityllumazine (9).
8
 The lumazine derivative then 
undergoes a self-disproportionation reaction giving riboflavin (1).
9
  
 
 
  
 
 
Figure 2: Biosynthetic pathway of riboflavin in microorganisms.  
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1.3 Riboflavin as a cofactor  
After the biosynthesis or uptake of riboflavin in the cells, it is converted to its 
active cofactor forms FMN (2) and FAD (3) via two steps.
10
 In the first step, riboflavin 
(1) is converted to FMN (2) by flavokinase. FMN (2) serves as the cofactor in some 
functional flavoenzymes which include NAD(P)H oxidases, chorismate synthase, 
alkanal monoxygenase, thymidylate synthase.
11-13
 In the second step FAD synthase 
converts FMN (2) to FAD (3) which serves as the more common cofactor in several 
oxidoreductase enzymes including glucose oxidase, glutathione reductase.
14
 Therefore, 
these two metabolically active forms of riboflavin (1), serve as redox cofactors in a 
variety of metabolic transformations. In most of these enzymes the flavin moiety is 
tightly bound, non-covalently at the active site of the proteins.
15
 In a few others, they are 
covalently attached to either the 8α-methyl group or to the C6 atom of the flavin 
isoalloxazine ring with amino acid side chains of the protein.
16
 
1.4 Regulation of riboflavin concentration in the cell 
To complete the catalytic cycle in flavoenzymes, the reduced flavin cofactor is 
re-oxidized, and in some systems like the ErV family Sulfhydryl oxidases, this cycle 
produces superoxide as toxic reactive oxygen species.
17
 Conversely, reactive oxygen 
species like superoxide and hydroxyl radicals can also be generated from oxidized flavin 
molecule non-enzymatically by exposure to light in the presence of electron donors like 
amino acids.
18
 In order to protect the cells from these reactive species, the concentration 
of riboflavin (1) in the cells is strictly maintained under a certain threshold level. Several 
intestinal bacteria oxidize riboflavin (1) to 7α and 8α-carboxyriboflavin (10,11) 
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(Appendix A), N10-hydroxyethylflavin (85) or lumichrome (12) (Figure 3).
19
 These 
catabolites are then excreted through the urine. The oxidative degradation pathways for 
riboflavin (1) is absent in humans and are found only in bacteria and in certain fungi.
20
  
1.5 Riboflavin catabolism in bacteria 
 Cofactor catabolism has long been a greatly unexplored field of research.
21
 
Heme, nicotinamide and PLP are the only three cofactors for which the catabolic 
pathways are well characterized.
22-24
 During 1940-1970 a number of cofactor catabolic 
strains were isolated including thiamin, folate, biotin and riboflavin catabolic strains.
25-28
 
Among these identified cofactor catabolic strains a riboflavin degrading soil bacterium 
Pseudomonas riboflavina was discovered by the Foster group in 1944 which degraded 
riboflavin (1) to lumichrome (12).
29
  
In 1956, riboflavin hydrolase, was identified by the same group in the crude cell-
free extract of Pseudomonas riboflavina that could cleave riboflavin to give  lumichrome 
(12) and ribitol (13) as the end products (Figure 3).
30
 Further attempts to identify the 
gene encoding the enzyme and characterize the enzyme have been unsuccessful. 
In 1965, the Stadtman group demonstrated the degradation of the isoalloxaxine 
ring of riboflavin (1) to 1-ribityl-2,3-diketo-1,2,3,4-tetrahydro-6,7-dimethylquinox-
1,2,3,4-tetrahydro-6,7-dimethylquinoxaline (14) releasing ribose (15), urea (16), and 
CO2 (17) with the cell-free enzyme preparations from a Pseudomanas RF strain (Figure 
4).
28
 14 was degraded further by the same strain to the lactone (18) and oxalimide (19).
31
 
Unfortunately, even this strain could not be recovered for further analysis. 
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1.6 Riboflavin catabolic gene cluster 
 In 2012, the Begley Lab discovered a riboflavin (1) degrading strain 
Microbacterium maritypicum G10. Successive cosmid library screening has revealed 
that this bacterium contains a gene cluster responsible for riboflavin catabolism. The 
gene cluster contains an enzyme riboflavin lyase (RcaE) that catalyzes the degradation 
of riboflavin (1) to lumichrome (12) and ribose (15) in the presence of oxygen (20) and 
reduced nicotinamide cofactor NADH (22). Along with rcaE the other functional genes 
in the cluster that are involved in riboflavin catabolism encode for a flavin reductase 
RcaB, a flavokinase RcaA and a ribokinase RcaD. RcaA, RcaB and RcaD have been 
Figure 4: Isoalloxazine degradation by bacteria 
Figure 3: Riboflavin degradation by riboflavin hydrolase from Pseudomonas riboflavina 
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reconstituted in our lab. Also, reconstitution of RcaE has been carried out. The proposed 
sequential functions of the enzymes involved in the catabolism of riboflavin are shown 
in Figure 5. 
 
 
 
Figure 5: The proposed sequential activities of the riboflavin catabolic enzymes. Riboflavin (1) 
uptaken by cells from the environment is converted to FMN (2) by the flavokinase RcaA. The FMN 
in turn is reduced by the NADH (22) dependent flavoreductase RcaB. The reduced FMN (2) is then 
transferred to the riboflavin catabolizing enzyme RcaE where it assists in the degradation of 
riboflavin (1) to lumichrome (12) and ribose (15). The ribose released by RcaE is phosphorylated by 
the ribokinase RcaD to form ribose-5-phosphate (24) which enters central metabolism. 
 
 
1.7 Riboflavin Lyase (RcaE) 
The riboflavin degradation pathway in Microbacterium maritypicum G10 is 
similar to the previously proposed riboflavin degradation pathway in Pseudomonas 
riboflavina.
29
 The reaction catalyzed by the purified riboflavin lyase (RcaE) from the 
Microbacterium strain involves an oxidative cleavage of riboflavin (1) at the C1' position 
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to produce lumichrome (12) and ribose (15) (Figure 6). Unlike riboflavin degradation in 
Pseudomonas RF
28,31
 where further degradation of the isoalloxazine ring (lumichrome) 
is observed, the end product for both riboflavin hydrolase from Pseudomonas 
riboflavina
32
 and RcaE from Microbacterium maritypicum G10 is lumichrome (12).  
Chemical photolytic degradation of riboflavin (1) to lumichrome (12) under 
alkaline conditions is well-precedented in the literature.
33
 RcaE mimics this non-
enzymatic transformation in absence of light under neutral conditions. Consistent with 
our experimental data, RcaE requires the presence of oxygen (20) and the flavin 
reductase system RcaB with the reduced nicotinamide cofactor NADH (22) for its 
activity. Since the NADH (22) utilizing flavin reductase RcaB is present in the same 
gene cluster as RcaE we propose that the oxidative transformation by RcaE is brought 
about by a reduced flavin cofactor received from the partner reductase RcaB.
34
 
 
 
 
Figure 6: The degradation of riboflavin (1) to lumichrome (12) and ribose (15) catalyzed by 
RcaE 
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1.8 Riboflavin Lyase (RcaE) is a two-component flavin monooxygenase 
Oxidative flavoenzymes 
Thus, RcaE falls in the broad class of flavoenzyme oxygenases, which harbor a 
large number of interesting enzymes involved in different substrate oxidation. Oxidative 
flavoenzymes can be broadly classified into two classes, flavin oxidases and flavin 
oxygenases.
35,36
 Flavin oxidases bind to oxidized flavin, which oxidizes substrates via a 
reductive half reaction. Examples of such oxidases include flavoenzymes that catalyze 
desaturations to olefins; oxidation of amines, alcohols, and thiols; and flavin-N5 
mediated oxidation of nitroalkanes.
37
 Flavin oxygenases, on the other hand, bind to 
reduced flavin which in turn oxidizes substrates through a re-oxidative half reaction with 
oxygen.
38
 Flavin oxygenases can be subdivided into single component and two-
component flavin monoxygenases.  
Single and two-component flavin oxygenases 
In single component flavin oxygenases, the reduction of the bound flavin by a 
nicotinamide cofactor as well as the reaction of the reduced flavin with molecular 
oxygen to form the active oxidizing species takes place on a single protein. The 
extensively studied enzyme system, para-hydroxybenzoate hydrolase, which oxidizes p-
hydroxybenzoate (25) to dihydroxybenzoate (26), serves as a model for this class of 
monoxygenases (Appendix B).
39
  
Two-component flavin oxygenases on the other hand, consist of an oxidase 
component that utilizes reduced flavin, generated by a separate NAD(P)H dependent 
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flavin reductase component, to activate oxygen for substrate oxidation.
40
 Bacterial 
luciferase serves as the model system for this class of enzymes. This enzyme catalyzes 
the oxidation of reduced FMN with oxygen producing bioluminescence.
41
 Apart from 
luciferase, this family includes flavoenzymes that catalyze C4α-(hydro)peroxyflavin (27) 
(Appendix C) mediated hydroxylation, epoxidation, chlorination, oxidative amide 
hydrolysis, Baeyer-Villiger oxidation, oxidative Favorskii rearrangement; flavin-N5-
oxide (28) (Appendix C) mediated oxidations and a unique transformation where the 
flavin molecule is destructively converted to dimethylbenzimidazole (43) (Figure 7).
42,43
  
 
 
  
Figure 7: Reaction mechanism of two-component flavin oxygenases. The different types of 
oxidations catalyzed by this class of enzymes are summarized. 
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Flavin reducing systems for 2 ē reduction 
In biological systems, flavins are reduced by the reduced nicotinamide cofactor 
NAD(P)H which is either bound to the same protein component as the flavin or is bound 
to a partner reductase component. FMN (2) is reduced by E.coli flavin reductase at a 
very fast rate with a kcat of ~32 s
-1
.
44
 Though the non-enzymatic reduction of flavins with 
NADH in the absence of a flavin reductase proceeds at a much slower rate, this 2 ē 
reduction can also be achieved non-enzymatically at comparable rates by reducing 
agents like dithionite (44) (Appendix A).
45
 Here, the reduction proceeds by two single 
electron transfers from dithionite.
46
 Flavins can also be efficiently reduced by 
photoreduction with single electron donors like EDTA (45) (Appendix A)
47
 and amino 
acids
48
 via the formation of a flavin semiquinone from the flavin in its triplet state. In 
monoxygenases, the formation of the 2 ē reduced flavin is necessary for its reaction with 
molecular oxygen to produce the active oxygenating species C4α-(hydro)peroxyflavin 
(27) (Appendix C). 
RcaE – Two-component flavin monooxygenase with RcaB as partner reductase 
RcaE catalyzes an oxygen mediated oxidative degradation of riboflavin to 
lumichrome. This degradation requires reduced FMN which may be delivered to RcaE 
by the flavin reductase RcaB. Hence, RcaE is proposed to be a member of the two-
component flavin oxygenases where RcaE serves as the oxidase component and RcaB as 
the reductase counterpart. From the experimental results obtained in the following 
chapters, the mechanism of riboflavin degradation by RcaE is proposed to proceed via 
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an unprecedented superoxide radical mediated mechanism. This makes RcaE a unique 
member of the two-component flavin oxygenase family.    
In this work, we report the reconstitution of RcaE followed by a mechanistic 
description of the enzyme. Through mechanistic studies with analogs and with 
intermediates, we have elucidated the identity of the active oxidizing species responsible 
for the oxidative degradation of riboflavin by the enzyme.  
CHAPTER II 
ANNOTATION AND RECONSTITUTION OF THE CATABOLIC GENE CLUSTER 
FOR RIBOFLAVIN IN MICROBACTERIUM MARITYPICUM G10 
2.1  
 Cofactors play key roles in augmenting the limited functionality available on 
proteins for catalysis. As with all other metabolites, cofactors do not accumulate in the 
environment. This is due in part to efficient salvage of these biosynthetically 
expensive metabolites and in part due to cofactor catabolism. However, in contrast to 
the large literature which is available on the biosynthesis of cofactors
21
 with 
relatively little information about their breakdown process.49 Till date, only a few 
cofactor catabolic pathways have been identified (Figure 8). Among the characterized 
catabolic pathways, the most well-studied is the enzymatic degradation for Vitamin B6 
(PLP) which proceeds via two independent pathways. In one of the pathways, 
pyridoxine (46) is degraded all the way to succinic semialdehyde (47), while in the 
second, it is degraded to 2-(hydroxymethyl)-4-oxobutanoate (48).
24
 The other well 
characterized catabolic pathway is the thiamine (Vitamin B1) catabolism where 
thiaminase I and thiaminase II cleave thiamine (49) to generate a pyrimidine 
fragment (50) and thiazole phosphate (51).
50,51
 In the heme degradation pathway, 
heme (52) is degraded to biliverdin (53) or staphylobilin (54) by heme-oxygenase.
23
 
Another example is the catabolic pathway for nicotinic acid (Vitamin B3) (55) which 
gets degraded aerobically to fumarate (56), carbon dioxide (17), ammonia (57) 
and formic acid (6) whereas the anaerobic degradation pathway generates 
pyruvate (58), propanyliumoate (59) and ammonia (57).
22,52
12 
Introduction
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Figure 8: Catabolic pathways for Vitamin B6, Vitamin B1, heme and Vitamin B3 
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Thiamin (49), folate (Vitamin B9) (60) (Appendix A), riboflavin (Vitamin B2) 
(1), biotin (Vitamin B7) (61) (Appendix A) degrading bacteria were once isolated but 
have now been lost.
25-27,53-55
 Analysis of culture metabolites from the reported riboflavin 
(1) catabolic strain demonstrated that this strain was capable of degrading the 
isoalloxazine ring of riboflavin all the way to the lactone (63) and oxalimide (64) (Figure 
9).
28
 None of the genes were identified and lumichrome was not an intermediate.   
 
 
 
 
 
 
 
 
 
 
RcaE, the riboflavin lyase, catalyzes the conversion of riboflavin (1) to 
lumichrome (12) and ribose (15) and has previously been identified as a potential 
catabolic enzyme in a second pathway identified by the Foster group in 1956.
32,56 
However, despite significant effort, the gene encoding this enzyme was never identified, 
and the enzyme itself proved to be biochemically intractable.
57
 Here we report the 
isolation of a riboflavin catabolizing Microbacterium maritypicum strain from dust 
samples obtained from the DSM riboflavin production plant in Germany. The catabolic 
Figure 9: Riboflavin (1) degradation – breakdown of the isoalloxazine ring 
15 
operon was identified from a cosmid library, then sequenced and annotated. Preliminary 
characterization of the enzymes involved suggested a riboflavin catabolic pathway.  
2.2 Results and Discussions 
Strain Microbacterium maritypicum G10 catabolizes riboflavin 
Dust samples, collected at the DSM riboflavin production plant in Germany, 
were screened by culturing in M9 medium with riboflavin as the sole carbon source. 
Bleaching of the riboflavin (1) color was observed in some of the samples. The cells 
from these hits were grown on NB plates and single colonies were selected. Individual 
strains were retested for conformation on M9 medium with riboflavin as the sole carbon 
source. The best of these strains (Strain G10) completely bleached the yellow color of 
riboflavin after 12 hours of growth and was selected for further study. The 16S rRNA 
sequence identified this strain as Microbacterium maritypicum. 
To identify the products generated from consumption of riboflavin (1), M. 
maritypicum G10 was grown in M9 medium supplemented with 0.1% LB and 100 μg/ml 
(270 μM) riboflavin (1). HPLC analysis of the medium showed time-dependent 
consumption of riboflavin (1) and appearance of a new signal, which co-migrated with 
lumichrome (12) (Figure 10A). Analysis after 21 hr showed complete catabolism of 
riboflavin, a small peak for lumichrome (12) and no new signals were observed on the 
HPLC. This result suggested that lumichrome (12) precipitates from the growth medium. 
After 30 hr, total concentration of lumichrome (12), from 270 μM riboflavin (1), was 
260 μM. This corresponds to 96% conversion of riboflavin (1) to lumichrome (12). 
When the same culture medium was filtered before basification, concentration of 
16 
lumichrome (12) was less than 25 μM (Figure 10B). We therefore conclude that 
riboflavin (1) catabolism in M. maritypicum G10 involves cleavage of the ribose (15) 
from the isoalloxazine ring. The ribose is used to sustain cell growth and the lumichrome 
(12) precipitates from the growth medium.
Identification of the riboflavin catabolic gene cluster 
A cosmid library was constructed for the isolation of the riboflavin (1) catabolic 
gene cluster.
58
 After failing to identify the gene cluster by screening this library in E.coli,
Streptomyces lividans was chosen as the heterologous host because Microbacterium and 
Streptomyces both have high genomic GC content. The cosmid library was therefore 
reconstructed in vector pJTU2463 containing oriT for conjugation and integration into 
the attP site of S. lividans. The genome size of Microbacterium is 4~5 Mb. and the 
resulting library consisted of eight 96-well plates. This library was screened, first in 
batches of 12 cosmids, then individually, to yield two cosmids encoding the riboflavin 
B A 
Figure 10: Analysis of riboflavin catabolism. A: HPLC analysis for the time dependent formation 
of lumichrome (12) from riboflavin (1) in the culture medium of M. maritypicum G10 at 340nm. B: 
UV-Vis analysis of culture medium treated with 1N KOH after ~30hours.  
17 
(1) catabolic pathway (1A4 and 5H7, Figure 11A). Sequence alignment of the two
cosmids identified a 6.63 kb region in 1A4 showing 86% identity with 5H7 suggesting 
that the riboflavin catabolic genes were localized in this region. To test this, an 8.7 kb 
BamHI fragment from 5H7, containing the target 6.63 kb region, was cloned into 
pJTU2463 and introduced into S.lividans. This strain after the introduction of pJTU2463 
consumed riboflavin (1). 
Functional analysis of the riboflavin catabolic (Rca) gene cluster 
The genetic organization of the riboflavin catabolic gene cluster of cosmid 5H7 
is shown in Figure 7B, and the gene annotations are shown in Table 1. The riboflavin (1) 
catabolic gene cluster on cosmid 1A4 was similarly annotated (Table 2). All of the genes 
in this cluster have high identity to those in the 5H7 cluster except for RcaH, which is 
replaced by a gene of unknown function (RcaJ2). Based on the sequence analysis, RcaF 
and RcaG are likely to be involved in riboflavin (1) transport and RcaC in pathway 
regulation. These proteins were not further studied. Cosmids 5H7 and 1A4 both contain 
all of the genes essential for riboflavin catabolism in S. lividans (Figure 11B). Since a 
second riboflavin kinase is available for FMN (2) and FAD (3) biosynthesis in 
S.lividans, RcaA is not an essential component of the catabolic gene cluster (see below).
In addition, since rcaH is missing from cosmid 1A4 and rcaJ2 is missing from cosmid 
5H7, we conclude that neither of these genes are involved in riboflavin (1) catabolism. 
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gene start stop 
Amino 
acid 
Protein homolog/ 
Proposed function 
Identity 
(%) 
RcaA 1585 1193 131 
Bifunctional riboflavin kinase Arsenicicoccus bolidensis/ 
Flavokinase 
70/129 
54% 
RcaB 2106 1585 174 
Flavin reductase Marine actinobacterium PHSC20C1/ 
Flavin-reductase 
87/159 
55% 
RcaC 2209 2811 201 
PadR family transcriptional regulator 
Salinibacterium sp. PAMC21357/ 
Transcriptional regulator 
120/186 
65% 
RcaD 3671 2820 284 
Ribokinase Llyobacter polytropus DSM 2926/ 
Ribokinase 
105/287 
37% 
RcaE 5073 3697 459 
N5,N10-methylene tetrahydromethanopterin reductase 
Bacillus sp. 10403023/ 
Riboflavin lyase 
139/340 
41% 
RcaF 6036 5191 282 
Transporter Marine actinobacterium PHSC20C1/ 
Transporter 
202/269 
75% 
RcaG 6826 6032 265 
ABC transporter ATP-binding protein 
Marine actinobacterium PHSC20C1/ 
Transporter 
189/258 
73% 
RcaH 5924 6859 312 
Phenol hydroxylase Natronorubrum tibetense/ 
Unknown 
53/165 
32% 
RcaI 7929 6829 367 
NMT1/THI5 like domain-containing protein 
Salinibacterium sp. PAMC 21357/ 
Unknown 
185/245 
76% 
Genes 
From 
5H7 
Genes 
From 
1A4 
Protein homolog 
Identity 
(%) 
RcaA 
Flavokinase 
Arsenicicoccus bolidensis 
RcaB RcaB2 
Flavin reductase 
Marine actinobacterium PHSC20C1 
132/160 
83% 
RcaC RcaC2 
PadR family transcriptional regulator 
Salinibacterium sp. PAMC 21357 
185/194 
95% 
RcaD RcaD2 
Ribokinase 
Llyobacter polytropus DSM 2926 
220/284 
77% 
RcaE RcaE2 
N5,N10-methylene tetrahydromethanopterin 
reductase Bacillus sp. 10403023 
434/459 
95% 
RcaF RcaF2 
Transporter 
Marine actinobacterium PHSC20C1 
269/282 
95% 
RcaJ2 Hypothetical protein 
RcaG RcaG2 
ABC transporter ATP-binding protein 
Marine actinobacterium PHSC20C1 
251/265 
95% 
RcaH 
Phenol hydroxylase 
Natronorubrum tibetense 
RcaI RcaI2 
NMT1/THI5 like domain-containing protein 
Salinibacterium sp. PAMC 21357 
344/367 
94% 
Table 1: Deduced functions of ORFs in the catabolic gene cluster of 5H7. 
Table 2: Comparison of gene annotations between the two gene clusters. 
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RcaA is a riboflavin kinase 
RcaA was cloned into the pET28b vector and overexpressed in E.coli BL21 
(DE3). The overexpressed enzyme was purified on a HisTrap HP column (Figure 12A). 
The purified enzyme was incubated with riboflavin (1) and ATP (21), and the product 
was identified as FMN (2) by HPLC confirming RcaA as a riboflavin kinase (Figure 
12B). 
B 
A 
Figure 11: Cloning of the riboflavin (1) catabolic cluster. A: S.lividans carrying cosmid 5H7 
bleached the M9 plate with riboflavin (right) compared to the mutant carrying cosmid 5H4 (left). 
B: Genetic organization of the riboflavin catabolic gene cluster from cosmid 5H7.   
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RcaB is a riboflavin/flavin mononucleotide (FMN) reductase 
RcaB was cloned into the pMAL vector and overexpressed in E. coli 
BL21(DE3). The overexpressed enzyme was purified on an amylose resin column. 
(Figure 13A). The purified enzyme was incubated with NADH (22) and riboflavin (1) or 
FMN (2) and a steady decrease in the absorbance at 450 nm for oxidized flavin was 
observed by UV-visible spectroscopy (Figure 13B). As evident from Figure 13B, a 
complete reduction of 80 µM FMN (2) was achieved in 80 secs with 100 nM RcaB in 
B 
A 
Figure 12: Biochemical characterization of RcaA. A: SDS/PAGE analysis of RcaA purified on a 
Ni-NTA His-Trap column. Lane 1: purified RcaA, Lane 2: molecular mass markers, B: HPLC trace 
of the RcaA catalyzed reaction of riboflavin (1) with ATP (21). Complete conversion of riboflavin (1) 
to FMN (2) in the full reaction with RcaA and ATP (21) (blue trace). The red trace shows the HPLC 
data in the reaction where the enzyme RcaA is absent. 
B 
21 
the presence of excess NADH (22) whereas similar reduction of riboflavin (1) required 1 
µM enzyme. In Figure 13C absorbance at 340 nm was monitored for NADH (22) 
consumption. Consumption of NADH (22) was measured for both FMN (2) (left panel) 
and riboflavin (1) (right panel) reduction with 100 nM RcaB. A comparison between the 
two panels (Figure 13F) indicates that the rate of reduction of FMN (2) by RcaB is much 
faster than the reduction of riboflavin (1). No change in the absorbance for oxidized 
flavin at 450 nm was observed when the flavin was incubated with NADH (22) in the 
absence of the enzyme (Figure 13D). Similarly, in the absence of oxidized flavin no 
decrease in the absorbance for NADH (22) at 340 nm was observed (Figure 13E). 
Together these results confirmed RcaB as a flavin reductase with a modest substrate 
preference for FMN (2) over riboflavin (1) (Figure 13F). 
RcaD is a ribokinase 
RcaD was cloned into the pMAL vector and overexpressed in E.coli BL21 
(DE3). The enzyme was purified as described for RcaB above (Figure 14A). RcaD 
catalyzed the conversion of ribose (15) to ribose-5-phosphate (24) in the presence of 
ATP (21). The product 24 was detected by LC-MS analysis of the reaction mixture after 
treatment with O-(2,3,4,5,6-Pentafluorobenzyl) hydroxylamine (PFBHA) (65) to convert 
the corresponding aldehyde to the ribose-5-phosphate-PFBHA oxime (67) (Appendix 
D), thus confirming RcaD as a ribokinase (Figure 14B, 14C).  
22 
Figure  13: Biochemical characterization of RcaB. A: SDS/PAGE analysis of RcaB after 
purification on a Maltose-binding column followed by maltose tag cleavage. Lane 1: purified RcaB, 
 Lane 2: molecular mass markers B: UV-visible spectra of the RcaB-catalyzed reduction of FMN (2) 
 with NADH (22) and 100 nM RcaB (left trace), UV-visible spectra of the RcaB-catalyzed reduction 
of riboflavin (1) with NADH (22) and 1 µM RcaB (right trace) C: UV-visible spectra of the RcaB- 
catalyzed oxidation of NADH (22) with FMN (11) and 100 nm RcaB (left trace), UV-visible spectra 
 of the RcaB-catalyzed oxidation of NADH (22) with riboflavin (1) and 100 nM RcaB (right trace). 
D: UV-visible spectra of non-enzymatic reduction of FMN (11) with NADH (22) E: UV-visible 
spectra of the RcaB-catalyzed oxidation of NADH (22) in the absence of flavin. F: Comparative 
 NADH oxidation rates by FMN (blue boxes) vs. riboflavin (red boxes) in the presence of RcaB. The 
r ate of oxidation of FMN (shown by the decrease in absorbance of NADH at 340 nm) is much faster 
than the rate of oxidation of NADH by riboflavin. 
B 
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Figure 13 Continued 
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Figure 14: Biochemical characterization of RcaD. A: SDS-PAGE analysis of RcaD after 
purification on a Maltose-binding column followed by maltose tag cleavage. Lane 1: purified RcaD, 
Lane 2: molecular markers, B: Extracted Ion Chromatogram (EIC) of RcaD catalyzed a reaction of 
ribose (15) with ATP (21) in the presence of PFBHA (65). The trace in yellow shows the no enzyme 
control where the PFBHA trapped substrate, ribose-PFBHA oxime (66) (Appendix D) (M+H
+
346.0712), is detected by the EIC at 346.07 Da. The blue trace is the full reaction where the product, 
ribose-5-phosphate-PFBHA oxime (67) (M+H
+
 426.0417), is detected by the EIC at 426.04 Da.
Ribose-PFBHA oxime (66) at EIC 346.07 was not detected in the full reaction demonstrating a 
complete conversion of ribose (15) to ribose-5-phosphate (24) by RcaD under the reaction 
conditions. C: ESI-Mass spectrum in the positive mode of the reaction product  67. 
B 
C 
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RcaE catalyzes the formation of lumichrome (12) 
RcaE was cloned into pET28b and overexpressed in E.coli BL21 (DE3). The 
protein was purified on a HisTrap HP column (Figure 15A). To test for RcaE activity 
riboflavin, NADH (22) and ATP (21) were incubated with purified RcaA, RcaB, RcaD, 
and RcaE and the reaction mixture was analyzed by HPLC. A time dependent formation 
of lumichrome (12) with the enzyme cocktail was observed (Figure 15B). In order to 
characterize the sugar product in the enzymatic degradation of riboflavin (1), the 
reaction mixture was treated with PFBHA (65) and analyzed by LCMS. The full reaction 
revealed the formation of ribose-5-phosphate-PFBHA oxime (67) (Figure 15C). The 
above results establish that RcaE is a riboflavin lyase.  
C A 
Figure 15: Biochemical characterization of RcaE. A: SDS/PAGE analysis of RcaE purified on a 
Ni-NTA His-Trap column. Lane 1: molecular mass markers. Lane 2: purified RcaE, B: HPLC trace 
of the RcaA, RcaB, RcaD, RcaE-catalyzed reaction of riboflavin with NADH (22) and ATP (21) 
showing time dependent formation of lumichrome (12). C: Extracted Ion Chromatogram (EIC) of the 
full reaction, after derivatization with PFBHA (65), showing EIC at 426.04 corresponding to the 
formation of ribose-5-phosphate-PFBHA oxime (67) (M+H+ 426.0417). 
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Figure 15 continued 
To further define the riboflavin lyase activity, a series of reactions, lacking 
individual components, were run (Figure 16). 
B 
lumichrome 
riboflavin 
FMN 
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Figure 16: HPLC characterization of the enzymatic formation of lumichrome (12) in the 
absence of individual participating enzymes. Formation of lumichrome (12) is observed when 
riboflavin (1) is incubated with RcaA, RcaB, RcaE (yellow trace). No consumption of riboflavin (1) 
is observed in the absence of RcaA (red trace). Reduced lumichrome (12) formation is observed in 
the absence of RcaB (green trace). The lumichrome (12) formation is observed due to the slow non-
enzymatic of FMN (2) by NADH (22). The reaction stops after the formation of FMN (2) from 
riboflavin (1) in the absence of RcaE (purple trace). 
These experiments established the following:  RcaA catalyzes the first step in the 
catabolic pathway because in the absence of RcaA, riboflavin (1) is not consumed and 
lumichrome (12) is not formed. RcaB catalyzes the second step because in its absence 
FMN (2) accumulates and very little lumichrome (12) is formed. In the absence of RcaE, 
FMN (2) also accumulates because any reduced flavin will undergo re-oxidation during 
aerobic work-up. Remarkably, addition of catalytic amounts of FMN (2) removes the 
RcaA requirement thus enabling reconstitution of the riboflavin lyase using RcaB, RcaE, 
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NADH (22) and catalytic amounts of FMN (2) (Figure 17). The lyase reaction is 
oxygen-dependent and the reaction products are lumichrome and ribose (Figure 18). 
2.3 Experimental 
Materials  
Riboflavin (1), FMN (2), NADH (22), O-(2,3,4,5,6-Pentafluorobenzyl) 
hydroxylamine (PFBHA) (65) and ribose-5-phosphate  (24) were purchased from 
Sigma-Aldrich. The commercial FMN (2) comes with small amounts of riboflavin and 
lumichrome as impurities. The impurities could not be eliminated after a round of HPLC 
purification of FMN due to the spontaneous degradation of FMN (2). Commercial 
Figure 17: HPLC trace for the RcaE enzymatic reaction with RcaB and NADH (22) in the 
absence of the flavokinase RcaA. Formation of the product lumichrome (12) is not observed (red 
trace). Lumichrome (12) formation is observed when catalytic amount of FMN (2) is added to the 
enzymatic reaction (blue trace). 
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riboflavin (1) also has trace amount of lumichrome as impurity which shows up as a 
trace peak on the HPLC only with high concentrations (~500 µM) riboflavin (1). The 
dehydrated form of LB broth and minimal medium salts were purchased from EMD 
Millipore. Kanamycin and IPTG were purchased from Lab Scientific Inc. Amicon Ultra 
centrifugal filter devices (10,000 MWCO) were obtained from Millipore. Histrap 
column was obtained from GE Healthcare. Econo-Pack 10DG desalting columns were 
purchased from Bio-Rad. 
 
 
Figure 18: HPLC trace for oxygen concentration dependent enzymatic formation of 
lumichrome (13). The RcaE enzymatic reactions are run for 10 mins in the presence of riboflavin 
(1), FMN (2), RcaB, NADH (22) and oxygen (20) concentrations varying from 25 – 125 µM. No 
lumichrome (12) formation is observed under anaerobic conditions as indicated by the pink trace. 
The tiny peak of lumichrome (12) in the pink trace comes as a contaminant with the commercially 
obtained FMN (2) and is also present in reactions where the enzyme RcaE is absent.   
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General materials 
All chemicals were purchased from Sigma-Aldrich. A dehydrated form of LB 
broth was purchased from EMD Millipore. Kanamycin and IPTG were obtained from 
Lab Scientific Inc. Amicon Ultra centrifugal filter devices (10,000 MWCO) were 
obtained from Millipore. Histrap Ni-NTA columns were obtained from GE Healthcare. 
Econo-Pack 10DG desalting columns were purchased from Bio-Rad. The baffled ultra 
yield flasks (2.5 L) for cell growth were obtained from Thomson Instrument Company. 
The ZORBAX Eclipse XDB-C18 column (15 cm x 4.6 mm, 5 μm particles) was 
purchased from Agilent Technologies. 
Bacterial strains and plasmids, culture conditions, general techniques 
Streptomyces lividans 1326 was used as the heterologous host for cosmid library 
screening for the riboflavin (1)  catabolic gene cluster. S.lividans 1326 and its derivatives 
were grown at 30°C on soy flour-mannitol (SFM) agar plates for sporulation and 
conjugation. E. coli DH5α was used for plasmid construction, and S17-1 was used for 
E.coli-Streptomyces conjugation. BL21 (DE3) was used for protein overexpression and
Epi100
TM
 from Epicentre was used for cosmid library construction. The cosmid library
was constructed with vector pJTU2463,
59
 which is a derivative of pOJ446 with the SCP2
replicon replaced by int and attp from pSET152.
60
 Plasmid pXH1 was cloned by
inserting an 8.7 kb BamHI fragment from cosmid 5H7 into BamHI/CIP treated 
pJTU2463. The strains and plasmids used are listed in Table 3. 
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Isolation of a riboflavin (1) catabolizing strain 
Riboflavin (1) catabolic strains were isolated from the dust at the DSM 
riboflavin-producing plant (Germany). Bacteria from dust samples were cultured in 
modified M9 medium (no glucose, 0.1 mM of FeCl3, 0.1% LB, 100 μg/ml of riboflavin) 
for several days. The growing cells were plated on NB plates and single colonies were 
selected to make a collection. Individual strains were then inoculated into 5 ml of NB 
and cultured at 30°C overnight. 1% of each starter culture was inoculated into 50 ml of 
modified M9 medium. The best strain catabolized riboflavin (1) within 12 hours and was 
selected for further study. 16s rRNA was amplified by PCR with primers FD1 (5'-
CCGAATTCGTCGACAACAGAGTTTGA-3') and RP2 (5'-
CCCGGGATCCAAGCTTACGGCTACCT-3').
61
 The sequence results suggested that
this riboflavin catabolic strain had high homology with M. maritypicum strain 
DSM12512, and it was named M. maritypicum G10. 
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Strain/plasmid Relevant characteristics Reference or 
source 
Actinomyces 
Microbacterium 
maritypicum G10 
Wild-type strain catabolizing riboflavin This study 
Streptomyces 
lividans 1326 
Heterologous host for screening riboflavin 
catabolic gene cluster 
1 
E.coli
Epi100
TM
Host cell for construction of genomic 
library 
Epicentre 
S17-1 TpR SmR recA, thi, pro, hsdR-M+RP4: 2-
Tc:Mu: Km Tn7 λpir 
3 
DH5 F- endA1 glnV44 thi-1 recA1 relA1 gyrA96
deoR nupG Φ80dlacZΔM15 Δ(lacZYA-
argF)U169, hsdR17(rK
-
 mK
+), λ–
Invitrogen 
BL21(DE3) F– ompT gal dcm lon hsdSB(rB
-
 mB
-) λ(DE3
[lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
Novagen 
plasmid 
pOJ446 aac(3)IV, SCP2, rep
pMB1*, attФC31, oriT 1 
pSET152 aac(3)IV, lacZ, rep
pMB1*
,attФC31, oriT 1 
pJTU2463 For construction of genomic library. A 
derivative of pOJ446 with SCP2 replicon 
replaced by int and attp from pSET152 
Yao et al. 
unpublished 
pXH-1 pJTU2463 carrying 8.7 kb BamHI from 
5H7 
This study 
pET28b Kan, rep
pBR322
, T7 promoter Novagen 
pXH-2 pET28b carrying ORF24 This study 
cosmid 
5H7 pJTU2463 derived comid containing 
riboflavin catabolic gene cluster 
This work 
1A4 pJTU2463 derived comid containing This work 
Table 3: Strains and plasmids used. 
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Identification of the products of riboflavin (1) catabolism 
M.maritypicum G10 was inoculated into 5 ml NB and grown overnight. The
starter culture (1%) was inoculated into 50 ml of fresh M9 medium with riboflavin (1) as 
the only carbon source. The cultures were grown in the dark at 30°C for ~4 days. For 
HPLC analysis, 200 ul of culture medium was filtered at various time points using 10 
kDa filters and 100 ul of the filtrate was injected onto the HPLC column. To determine 
total lumichrome (12) produced, 500ul of culture medium was mixed with 500ul of 1N 
KOH and the UV-Visible spectrum of the resulting mixture was recorded.
62
 The
concentration of lumichrome (12) was determined using a calibration curve constructed 
using known quantities of lumichrome (12) (2 μg/ml to 80 μg/ml) dissolved in a basic 
growth medium. 
Cosmid library screening for the riboflavin catabolic gene cluster 
The cosmid library was constructed in vector pJTU2463 containing oriT for 
conjugation and integration into the attP site of S. lividans. The genome size of 
Microbacterium is 4~5 Mb. and the resulting library consisted of eight 96-well plates. 
The cosmid mixture from combining each row (12 samples) of the 96-well plates was 
transformed into E.coli S17-1 and then introduced into S.lividans by conjugation 
(https://www.elabprotocols.com/viewer/?id=504)
63
 to give the corresponding S.lividans
mutant mixture. Sixty four conjugations were carried out and all the spores of the 
conjugants from each plate were collected to make one glycerol stock. Each mixture was 
tested on an M9 riboflavin plate for color bleach. After 7 days at 30 °C, plates with 
mutants carrying cosmid mixtures from Plate 1, row A (1A) and Plate 5, row H (5H) 
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bleached the riboflavin. Each of the 24 cosmids from rows 1A and 5H was then 
individually introduced into S.lividans and tested on modified M9 agar plates at 30°C for 
a week. The bottom layer of the modified plates was M9 medium (no glucose) with 
1.6% of agar. The top layer was M9 medium (no glucose), 1.6% agar, 100 μg/ml of 
riboflavin (1) and 40 μl of spore stock. Two mutants (1A well 4 and 5H well 7) 
consumed riboflavin (1) (Figure 11A).  
Sequencing and annotation of the riboflavin catabolic gene cluster 
Next generation sequencing of cosmids 1A4 and 5H7 was performed by AgriLife 
Genomics and Bioinformatics Services at Texas A&M University using an Illumina 
HiSeq 2100 instrument. The raw sequence data was analyzed with FramePlot 4.0 Beta 
and annotated using the BLAST algorithm (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and 
the SEED (http://theSEED.org).  
Cloning and overproduction of recombined His-tagged RcaE and RcaA 
The rcaE gene was amplified by PCR using cosmid 5H7 as the template (F 
primer: 5'-AAAA CATATG ACCGATCAGAACACCGT-3', R primer: 5'-AAAA 
GAATTC AGA CACGCGACATCGTC-3', engineered NdeI and EcoRI site are in 
italics). The PCR product was digested with NdeI and EcoRI and ligated into pET28b 
(NdeI/EcoRI) to generate plasmid pXH-2. This was transformed into BL21 (DE3). The 
transformants were grown in 3 L of LB medium with 40 μg/mL of kanamycin at 37°C to 
an OD600 of 0.5. IPTG was added to a final concentration of 0.4 mM and incubation was 
continued at 15 °C for 18 hours. The His-tagged RcaE was purified on a HisTrap HP 
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column (GE) and buffer-exchanged into 50 mM KH2PO4, 300 mM NaCl, 10% glycerol, 
pH 7.5 by passing through an Econo-Pac 10DG desalting column (Bio-rad). The protein 
was frozen in liquid nitrogen and stored at -80 °C. RcaA cloned into the pTHT vector 
and purchased from Genscript. The His-tagged RcaA was overexpressed and purified 
using the same procedure used for RcaE.  
Cloning and overproduction of RcaB and RcaD 
The rcaB gene was amplified by PCR using cosmid 5H7 as the template (F 
primer: 5'-AAAA CATATG ACGACTGTCGTGACCGA-3', R primer: 5'-AAAA 
CTCGAG TTA CGCGCTCTCGGGAGC-3', engineered NdeI and XhoI site are in 
italics). The PCR product was digested with NdeI and XhoI and ligated into pMAL 
(NdeI/XhoI) to generate plasmid pXH-3. The plasmid was transformed into BL21 
(DE3). The transformants were grown in 3 L of LB medium with 100 μg/mL of 
ampicillin and 0.5% glucose at 37°C to an OD600 of 0.6. IPTG was added to a final 
concentration of 0.4 mM and the incubation was continued at 15 °C for 18 hours. RcaA 
was purified on an amylose resin column followed by cleavage of the maltose tag with 
Factor Xa protease. The solution was then passed through an amylose resin column 
where the maltose tag was retained in the column, and the pure protein was recovered as 
the flow-through. The purified protein was then exchanged into 50 mM KH2PO4, 300 
mM NaCl, 10% glycerol, pH 7.5 by passing through an Econo-Pac 10DG desalting 
column (Bio-rad). The protein was frozen in liquid nitrogen and stored at -80 °C. RcaD 
was similarly overexpressed and purified.  
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Reconstitution of the RcaA-catalyzed reaction 
A reaction mixture (100 μL) of 20 μM RcaA, 250 μM riboflavin (1), 5 mM ATP 
(21), 5 mM MgCl2 (68) was incubated in potassium phosphate buffer at pH 7.5 at 37 °C 
for 15 mins. After the incubation period, the enzyme was removed by ultrafiltration (10 
kDa cut-off filter) and the reaction mixture was analyzed by HPLC followed by LC-MS. 
Reconstitution of the RcaB-catalyzed reaction 
RcaB was cloned into the pMAL vector and overexpressed in E. coli 
BL21(DE3). The overexpressed enzyme was purified on an amylose resin column. A 
reaction mixture (1 mL) containing 100 nM RcaB, 250 μM NADH (22), 80 μM FMN 
(2) (Figure 13B – left trace) OR 1 µM RcaB, 250 μM NADH (22), 80 μM riboflavin (1)
(Figure 13B – right trace) was placed in a quartz cuvette and the reaction was monitored 
by following the reduction in the spectrum of oxidized flavin between 400 and 510 nm  
by UV-visible spectroscopy. Similarly 20 nM RcaB was incubated with 50 μM NADH 
(22) and 20 μM riboflavin (1) (or FMN (2)) to monitor the relative rates for the
consumption of NADH (22) (Figure 13C) in the enzymatic reaction between 290 and 
410 nm for FMN (2) (left trace) versus riboflavin (1) (right trace). As negative controls 
the non-enzymatic reduction of FMN (2) was monitored between 400 and 510 nm 
(Figure 13D). Also the oxidation of NADH (22) by RcaB in the absence of flavins was 
monitored between 290 and 410 nm (Figure 13E). 
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Reconstitution of the RcaD-catalyzed reaction 
A reaction mixture (100 μL) containing 20 μM RcaD, 10 mM ATP (21), 5 mM 
MgCl2 (68), 250 μM ribose (15) was incubated in potassium phosphate buffer at pH 7.5 
at 37 °C for 10 mins. Protein was removed by ultrafiltration (10 kDa cut-off) and the 
product was converted to the corresponding oxime by treatment with PFBHA (65) at 65 
°C for 1 hour and analyzed by LC-MS. 
Analysis of the reaction mixture of RcaE 
A reaction mixture (100 μL) containing 10 μM RcaE, 100 nM RcaA, 1 μM 
RcaB, 10 μM RcaD, 500 μM riboflavin (1), 5 mM NADH (22), 5 mM ATP (21) and 5 
mM MgCl2 (68) was incubated in potassium phosphate buffer at pH 7.5 at 37 °C for 0, 1, 
2, 5 and 10 mins. Protein was removed by ultrafiltration (10 kDa cut-off filter) and the 
reaction mixture from each time point was analyzed by HPLC. 
Requirement for FMN in the RcaE reaction 
A reaction mixture (100 μL) containing 4 μM RcaE, 400 nM RcaB, 200 μM 
riboflavin (1), 5 mM NADH (22), 5 mM MgCl2 (68) and 5 mM ATP (21) in the absence 
of RcaA was incubated at 37 °C for 10 mins. In a second reaction mixture, 20 µM FMN 
(2) was added to the mixture (100 µL) with  20 μM RcaE, 4 μM RcaB, 200 μM
riboflavin (1), 5 mM NADH (22), 5 mM MgCl2 (68) and 5 mM ATP (21). Protein was 
removed by ultrafiltration (10 kDa cut-off filter) and the two reaction mixtures (with and 
without catalytic amounts of FMN) were analyzed by HPLC (Figure 17). 
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Oxygen requirement for RcaE reaction 
In the glove box, a reaction mixture (100 μL) containing 10 μM RcaE, 1 μM 
RcaB, 200 µM FMN, 500 μM riboflavin (1), 5 mM NADH (22), 5 mM MgCl2 (68) and 
5 mM ATP (21) was incubated at 37 °C for 10 mins with 25, 50, 100, 125 uM oxygen 
(20) prepared by appropriately diluting aerobic buffer containing 260 µM oxygen with
anaerobic buffer. A reaction with identical conditions was set up in the presence of 
anaerobic buffer. Protein was removed by ultrafiltration (10 kDa cut-off filter) and the 
reaction mixture from each oxygen concentration was analyzed by HPLC. 
Analysis of the ribose-phosphate 
The reaction mixture after incubation for 10 mins with the enzyme cocktail was 
treated with PFBHA (65) at 65 °C for 1 hour and the corresponding oxime was analyzed 
by LC-MS (Figure 15C).  
2.4 Conclusion 
Gene cluster identification for riboflavin degradation in Microbacterium maritypicum 
G10 
Initial screenings for riboflavin catabolic organisms in soil and sewage samples 
from various locations were unsuccessful. This suggested that it was necessary to screen 
from environments richer in riboflavin (1). With this in mind, riboflavin (1) catabolic 
microorganisms were readily isolated from dust samples obtained at the DSM riboflavin 
production plant in Germany. From these M. maritypicum G10, capable of growth on 
riboflavin (1) as the sole carbon source, was isolated. HPLC analysis of the growth 
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medium from this strain demonstrated the conversion of riboflavin (1) to lumichrome 
(12) (Figure 10A). Recently another strain of M. maritypicum was isolated from soil
samples in Japan and optimized for lumichrome (12) production. The catabolic operon in 
this strain was not characterized.
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A cosmid library, prepared from M. maritypicum G10, was screened in S.lividans 
and two cosmids encoding a riboflavin catabolic cluster were identified.
 
Sequence 
analysis revealed that the two gene clusters (86% identity, Tables 1 and 2) were on 
different locations in the genome. Derived on sequence similarity and in vivo screening 
of the BamHI fragments of one of the cosmids, the gene cluster was localized to a 
6.63kb DNA fragment. This DNA segment had 8 open reading frames (Figure 11A and 
Table 1). Biochemical studies were focused on identifying the reactions catalyzed by 
four open reading frames encoding for RcaA, RcaB, RcaD, and RcaE. Derived on the 
sequence analysis it was inferred that RcaF, and RcaG were likely to be involved in 
riboflavin (1) transport and RcaC in pathway regulation. RcaH was not studied further 
because it is not present in the second catabolic cosmid (1A4).  
Role of individual genes in the riboflavin catabolic gene cluster 
RcaA, RcaB, and RcaD were overexpressed and their predicted activities as 
riboflavin kinase, riboflavin reductase and ribokinase, respectively, were confirmed. 
Sequence analysis of RcaE identified this enzyme as a possible riboflavin dependent 
N5,N10-methylene-tetrahydromethanopterin reductase. As this was the only remaining 
unassigned riboflavin binding protein in the catabolic cluster, it seemed reasonable that 
RcaE might function as a riboflavin lyase. In support of this hypothesis, it was possible 
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to demonstrate that a reaction mixture containing purified RcaA, RcaB, RcaD and RcaE 
catalyzed the conversion of riboflavin (1) to lumichrome (12) and ribose-5-phosphate 
(24) (Figure 15). Further simplification of the reaction mixture demonstrated that RcaB
and RcaE were sufficient to cleave riboflavin (1) to give lumichrome (12) and ribose 
(15) using FMN (2) as the RcaE cofactor (Figure 17).
A proposal for riboflavin catabolism in M. maritypicum G10 is shown in Figure 
19. In this proposal, RcaF and RcaG transport riboflavin into the cell (not shown). RcaA
phosphorylates riboflavin and RcaB reduces the resulting FMN (2) to generate the active 
form of the riboflavin lyase (RcaE) cofactor. Cleavage of FMN (2) to lumichrome (12) 
and ribose (15) is an oxygen requiring reaction. The final step of riboflavin catabolism 
involves ribose phosphorylation. The mechanism of riboflavin lyase does not follow any 
of the canonical motifs in flavoenzymology. One possibility is that reduced FMN (23) 
generates superoxide, which then triggers the ribose (15) cleavage reaction by hydrogen 
atom abstraction from C1' of the riboflavin ribose. The M. maritypicum G10 pathway is 
considerably simpler than a previously reported pathway in which culture medium 
metabolites indicated complete isoalloxazine degradation.
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 It is likely that cleavage of
the ribose from riboflavin terminates the M. maritypicum G10 catabolic pathway 
because of lumichrome (12) insolubility and that more extensive catabolism requires that 
the ribose (15) remains bound to the heterocycle throughout the early stages of the 
isoalloxazine degradation.   
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Figure 19: Proposed riboflavin catabolic pathway in M. maritypicum G10 
Phylogenetic distribution of RcaE 
A phylogenetic tree constructed for RcaE using the Fast Minimum Evolution 
Method is shown in Figure 20 and suggests that RcaE is narrowly distributed in bacteria. 
In addition to its intermediacy in riboflavin (1) catabolism, lumichrome (12) has been 
suggested as a generally important signaling molecule in plant microbe interactions. 
Lumichrome (12) activates the LasR bacterial quorum sensing receptor
65
 and
lumichrome (12) produced by Sinorhizobium is an enhancer of alfalfa root respiration 
and shoot growth.
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 The orthologs marked in red in the phylogenectic tree of RcaE
(Figure 20), show that RcaE is well distributed among rhizosphere bacteria like 
Azorhizobium caulinodans, several Bradyrhizobium species and root endophytes like 
Microbacteium sp. Root322, Leifsonia sp. Root4. The RcaE orthologs in these species 
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are likely to be involved in signaling rather than catabolism. Riboflavin catabolism in 
these species is likely to play an additional signaling role.   
Figure 20: Phylogenetic tree for RcaE. All orthologs with a 38% sequence identity or higher 
with RcaE have been included in the phylogenetic tree construction.  
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CHAPTER III 
 RECONSTITUTION OF RcaE, IDENTIFICATION OF THE COFACTOR AND 
KINETIC STUDIES FOR THE ENZYME 
3.1 Introduction 
As described in Chapter II, the conversion of riboflavin (1) to lumichrome (12) 
and ribose-5-phosphate (24) requires a cocktail of enzymes RcaA, RcaB, RcaD, and 
RcaE. This result suggested the need for de-convoluting the system to figure out the 
minimal set of components in the reaction required for the degradation. Ribose-5-
phosphate (24), and not the corresponding ribitol-5-phosphate (70) (Appendix A) is 
formed as one of the reaction products. This observation clearly suggests the degradation 
is not a simple hydrolysis but proceeds via an oxidation followed by cleavage of the 
sugar side chain on the flavin. This observation is supported by the fact that oxygen is a 
necessary component for the transformation (Figure 18). Also, the requirement of RcaA 
as one of the components of the reaction point towards the fact that FMN (2) might play 
an essential role in the activity of the enzyme. Previous attempts to reconstitute the 
enzyme have failed. So far, all the biochemical studies with this enzyme have been 
carried out with the crude cell-free extract containing the enzyme.
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In this chapter, we report the reconstitution of RcaE followed by elucidation of 
the individual roles of all the components required for the reaction. The steady-state 
kinetics for the enzyme has also been reported.  
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3.2 Results and Discussions 
Reconstitution of RcaE (RcaE) 
RcaE was incubated with riboflavin (1) as the substrate in the presence of excess 
NADH (22) under aerobic conditions. The reaction mixture was analyzed by HPLC 
(Figure 21). A new peak appeared in the full reaction (green trace) with same retention 
time as lumichrome (12).  
Figure 21: HPLC trace for the reconstitution of RcaE with riboflavin (1) as the substrate, FMN 
(2) as the cofactor and NADH (22) as the reducing agent. Slight formation of lumichrome (12)
from riboflavin was observed in the full reaction (1, 22 and RcaE) in the absence of FMN (2) in the 
reaction (green trace). Full conversion of riboflavin (1) to lumichrome (12) occured in the full 
reaction when FMN (2) was present in the reaction (cyan trace). The control reactions include no 
oxygen (20) control (red trace), no RcaE control (blue trace) and no substrate control (purple trace). 
In all the three controls minute levels (a blip in the chromatogram) of lumichrome (12) was observed 
due to contamination of lumichrome (12) in the FMN (2) obtained from a commercial source.  
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The product was further characterized as lumichrome (12) with LC-MS where peak with 
mass M+H
+
 of 243 Da corresponding to lumichrome (12) was observed only in the full
reaction (Figure 22). Due to the inefficient conversion of riboflavin (1) to lumichrome 
(12) with the above conditions, the reaction was further optimized for maximum activity.
A complete reconstitution of the enzyme was achieved with the introduction of catalytic 
amounts of FMN (2) in the reaction (Figure 21 cyan trace). FMN (1) did not act as a 
substrate for the enzyme and was regenerated at the end of the reaction. This indicated 
that FMN (1) acted as the cofactor assisting the cleavage of riboflavin (1) to lumichrome 
(12) and ribose (15).
 
Characterization of ribose (15) 
The ribityl chain derived product released from the reaction was detected by 
LCMS after derivatization with PFBHA (65) (Appendix A) (Figure 23A). The product 
Figure 22: LCMS characterization of lumichrome (12) formed from the RcaE reaction. A: EIC 
at 243.0822 Da corresponding to the M+H
+ 
of lumichrome (12) from the reaction (yellow trace) and 
for standard lumichrome (12) (green trace). B: ESI-MS in the positive mode for the EIC in A 
showing the formation of lumichrome (12). 
A B 
13 
46 
was identified as ribose-PFBHA oxime (66) (Appendix A) (M+H
+
 346.0711) by co-
elution with the standard (Figure 23B). 
Figure 23: Characterization of ribose as ribose-PFBHA oxime (66) from the RcaE reaction 
treated with PFBHA by LCMS. A: Extracted Ion Chromatogram (EIC) at m/z 346 Da for detection 
of ribose-PFBHA oxime (66) (M+H
+
 346.0711) in the full reaction with riboflavin (1), FMN (2),
NADH (22) and RcaE (red trace). The control reactions include no oxygen (20) control (black trace), 
no RcaE control (blue trace) and no substrate control (brown trace) where the formation of the oxime 
is not observed. B: Characterization of the EIC at 346 Da for ribose-PFBHA oxime (66) released 
from the reaction (red trace) by co-elution with EIC at 346 Da for the synthesized standard of 66 
(blue trace). 
Binding studies with RcaE 
The as-isolated enzyme did not show any UV-visible absorbance at 450 nm 
indicating that the protein did not come bound with either the substrate riboflavin (1) or 
the cofactor FMN (2). Binding studies in the glove box revealed that the enzyme initially 
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binds to the reduced form of FMN (23), which then activates the enzyme to bind with 
the oxidized form of the substrate riboflavin (1). A weak binding of riboflavin (1) in the 
oxidized to the protein is obtained in the absence of reduced FMN (23).   
Synthesis of deazaflavins 
An in-vitro reconstitution of the enzyme reinforces the fact that the enzyme binds 
riboflavin (1) and FMN (2) simultaneously in the two distinct binding sites. Oxygen (20) 
being one of the substrates for the enzyme, it was necessary to figure out which one of 
the flavins reacted with triplet di-oxygen to produce the active oxidizing agent in the 
reaction. In the past, 5-deaza analogs of flavins have been extensively used in flavin-
chemistry to shut down SET mechanisms with single electron acceptors like oxygen (20) 
(Fig. 24A).
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 The 5-deaza analogs for both riboflavin (1) and FMN (2) were synthesized
from 5-deazaFAD (71) (Appendix E). 5-deazaFMN (72) was prepared by 
phosphodiesterase treatment of 5-deazaFAD (71), whereas 5-deazariboflavin (73) was 
prepared by the treatment of 5-deazaFMN (72) with phosphatase (Figure 24B). 
Role of FMN as the cofactor 
Both 5-deazaFMN (72) and 5-deazariboflavin (73) were used in enzymatic 
reactions to probe the role of the individual flavins in molecular oxygen (20) activation 
(Figure 25A). No product formation was observed when the enzyme is incubated with 5-
deazaFMN (72) instead of FMN (2) in the presence of riboflavin (1) and dithionite (44). 
On the contrary, complete conversion of 5-deazariboflavin (73) to 5-deaza-lumichrome 
(74) was observed when 5-deazariboflavin (73) was used as the substrate instead of
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riboflavin (1) in a reaction containing FMN (2), dithionite (44), and the enzyme. 5-
deaza-lumichrome (74) was characterized by LCMS (Figure 25B). The above 
experimental results establish the role of FMN (2) as the cofactor involved in the 
chemistry with molecular oxygen (20). Riboflavin (1), on the other hand, does not 
participate in dioxygen chemistry and only serves as the substrate. 
Figure 24: Oxygen chemistry with deazaflavin analogs. A: Scheme indicating no 5-deazaflavin 
semiquinone radical formation (high energy pyridinyl system) on treatment of 5-deazaflavin with 
triplet oxygen (20). B: HPLC chromatogram for the enzymatic synthesis of 5-deazaFMN (72) from 5-
deazaFAD (71) on treatment with phosphodiesterase (red trace). The green trace shows the formation 
of 5-deazariboflavin (73) when 5-deazaFMN (72) is treated with CIP. Standard 5-deazaFAD (71) 
(blue trace). 
A 
B 
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Figure 25: RcaE enzymatic reaction with 5-deazaFMN (72) and 5-deazariboflavin (73). A: 
HPLC Chromatogram for the reactions with riboflavin (1) and FMN (2) showing the complete 
conversion of riboflavin to lumichrome (12) (blue trace). When FMN (2) and 5-deazariboflavin (73) 
are incubated with the enzyme a complete conversion to 5-deazalumichrome (74) is observed (red 
trace). No lumichrome (12) formation is observed in the reaction with 5-deazaFMN (72) and 
riboflavin (1) (green trace). No formation of 5-deazalumichrome (74) is observed when 5-deazaFMN 
(72) and 5-deazariboflavin (73) are incubated with the enzyme (purple trace).
Kinetics of RcaE 
To figure out intermediates in the course of the reaction, a kinetic analysis of 
RcaE was required. Initial rate plots were produced for varying concentrations of 
riboflavin in the presence of excess in the presence of FRE reducing system containing 
FMN (2) and NADH (22) and RcaB. From the slopes of the rate plots, a Michaelis-
Menten plot was generated using KaleidaGraph to determine the kcat and the Km. From 
the steady-state kinetic data analysis, the enzyme turns out to be a fast enzyme with a kcat 
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of 4.56 
+
 0.06  s
-1 
and a Km of 53.46 
+
 4.5 µM for riboflavin (Figure 26). This indicated a
catalytic efficiency, kcat/Km, of (8.53 
+
 0.73) × 10
4
 M
-1
 s
-1
.
Figure 26: Michaelis-Menten plot for RcaE with riboflavin. The kcat and Km values have been 
calculated for riboflavin as the substrate. 
3.3 Experimental 
Enzymatic reactions and HPLC parameters 
All enzymatic reactions were carried out in potassium phosphate buffer at pH 
7.5. An Agilent 1260 HPLC equipped with a quaternary pump was used. The system 
included a diode array UV-Vis detector and products were detected using absorbance at 
260 nm and 450 nm. The analysis was performed on a ZORBAX Eclipse XDB-C18 
column (15 cm x 4.6 mm, 5 μm particles, Agilent Technologies). 
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HPLC conditions (for C18 column) 
A-Water
B-10 mM ammonium acetate buffer, pH 6.6
C-Methanol
HPLC method 
0 min- 0% A 100% B, 4 min- 10% A 90% B, 10 min-25% A 60% B 15% C, 25 
min-20% A 30% B 50% C, 28 min-18% A 20% B, 62% C, 30 min-15% A 10% B 75% 
C, 32 min- 25% A, 75% B, 35 min- 0% A 100% B, 40 min- 0% A 100% B. 
LC-MS parameters 
LC-ESI-TOF-MS was performed using an Agilent 1260 HPLC system equipped 
with a binary pump and a 1200 series diode array detector followed by a MicroToF-Q II 
mass spectrometer (Bruker Daltonics) using an ESI source either in negative or positive 
mode. The analysis was performed on an LC-18-T column (15 cm x 3 mm, 3 μm 
particles, Supelco). 
LC conditions 
A – 5 mM Ammonium acetate buffer, pH 6.6 
B – 75 % Methanol and 25 % Water. 
LC method: (for positive and negative mode on MS) 
0 min-100% A, 2 min-100% A, 12 min- 
30% A 70% B, 20 min-30% A 70% B, 25 min-100% A, 35 min-100% A. 
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Reconstitution of RcaE  
A reaction mixture (100 μL) containing 5 μM RcaE, 10 μM FMN (2), 5 mM 
NADH (22) and 250 μM riboflavin (1) was incubated at 37 °C for 10 mins. Protein was 
removed by ultrafiltration (10 kDa cut-off filter) and the reaction mixture was analyzed 
by HPLC followed by LC-MS. 
Binding studies with RcaE 
Aerobic binding reactions were done with 250 µM RcaE, 500 µM each of FMN 
(2) and riboflavin (1) in both oxidized and reduced states. The enzyme was incubated
with FMN (2) and/or riboflavin (1) in phosphate buffer at pH 7.5 for 1 hour at room 
temperature. The enzyme solution was then buffer exchanged to fresh phosphate buffer 
at pH 7.5 to get rid of any excess unbound flavin. The enzyme was then denatured by 
heating at 100 °C for 2 mins. The enzyme was removed by centrifugation, and the 
remaining solution was then analyzed by HPLC to look for flavin bound to the enzyme. 
Similar binding experiments were carried out in the glove box with reduced flavins. The 
enzyme was buffer exchanged with anaerobic phosphate buffer to get rid of all the 
oxygen (20) in the solution before incubation with the reduced flavins. 
Enzymatic synthesis of deazaFMN and deazariboflavin 
5-deazaFAD was a gift from the Liu lab at the University of Texas at Austin. For
the enzymatic synthesis of 5-deazaFMN (72), an reaction volume of 100 uL reaction 10 
units of snake venom pyrophosphatase was incubated with 500 µM 5-deazaFAD (71) 
and 5 mM MgCl2 (68) for 2 hours at 37
o
C to achieve complete conversion. In order to
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convert 5-deazaFMN (72) to 5-deazariboflavin (73) 500 µM of 5-deazaFMN (72) was 
incubated with 10 units of CIP for 1 hour at 37
o
C.
Reactions with 5-deazaFMN (72) and 5-deazariboflavin (73) 
Three separate 100 uL reactions were set up. The first reaction contained 20 µM 
enzyme with 20 µM FMN (2) as the cofactor, 250 µM of riboflavin (1) as the substrate 
and 5 mM dithionite (44) as the reducing agent. The second reaction was similar to the 
first one except 20 µM of FMN (2) was used as the cofactor and 250 µM 5-
deazariboflavin (73) was added as the substrate. The third reaction had 20 µM of 5-
deazaFMN (72) as the cofactor and 250 µM of riboflavin (1) as the substrate. The forth 
reaction had 20 µM of 5-deazaFMN (72) as the cofactor and 250 µM of 5-
deazariboflavin (73) as the substrate. The reactions were incubated at 37
o
C for 15 mins
followed by filtration of the reactions using a 10 kDa cut-off filter. The filtrates were 
then analyzed by HPLC and LCMS.  
Kinetics of RcaE 
FMN (2) concentration was 50 µM and NADH (22) concentration was kept at 
saturation (5 mM) in the presence of 100 nM RcaB. The concentration of riboflavin (1) 
was varied from 20 – 500 µM in initial rate determination reactions with 500 nM 
enzyme. The formation of lumichrome (12) was quantified by HPLC using standard 
concentration curves. Reactions were carried out in 100 μL aliquots. The reactions were 
quenched at 3 s, 6 s, 10 s, 15 s, 20 s time points by denaturing the enzyme with 0.1 N 
HCl. Each time-point reaction was repeated in triplicates. The amount of lumichrome 
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(12) formed was plotted against the time points for each set of substrate concentrations.
The initial slopes from each set of substrate concentrations were then plotted against the 
substrate concentration and fit to the Michaelis−Menten equation using KaleidaGraph 
(Synergy Software). 
3.4 Conclusion 
Till date, all of the characterized flavoenzymes have been known to contain one 
flavin binding site. In contrast, RcaE, has two distinct flavin-binding sites. This has been 
shown by our experimental evidence for the requirement of two flavins for enzyme 
activity.  
In this chapter, we have elucidated the individual roles of all the reaction 
components required by RcaE for the conversion of riboflavin (1) to lumichrome (12). 
This enzyme serves as the first example where the reduced cofactor FMN (23) is 
required to catalyze the breakdown of a second flavin molecule, riboflavin (1). Binding 
studies along with deazaflavin enzymatic reactions have established that the enzyme 
binds FMN (2) in the reduced state and activates it towards an SET chemistry with 
molecular oxygen (20).   
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CHAPTER IV 
MECHANISTIC HYPOTHESIS FOR AN ACID-BASE MEDIATED DEGRADATION 
OF RIBOFLAVIN TO LUMICHROME BY RcaE 
4.1 Redox chemistry leading to the formation of lumichrome (12) 
Under initial reconstitution conditions, RcaE was treated with riboflavin in the 
presence of reduced nicotinamide cofactor NADH (22) to yield lumichrome (12) and 
ribose (15) (Figure 21 green trace). As a preliminary mechanistic hypothesis for 
riboflavin degradation by the enzyme, the oxidized form of the nicotinamide cofactor 
NAD
+ 
(75) was proposed to act as the cofactor (Figure 27). The source of NAD
+ 
(75)
was assumed to be the commercial NADH (22) samples where the oxidized cofactor is a 
contaminant due to aerial oxidation. The limited availability of NAD
+ 
(75) in the
reaction mixture explained the inefficient conversion of riboflavin to lumichrome (12) 
under the reaction conditions.  
In order to test the mechanistic hypothesis, further experiments were performed 
with externally added NAD
+ 
(75). Interestingly, no lumichrome (12) formation was
observed in the reaction, indicating that the cofactor required for the transformation is 
probably NADH (22) itself. Also, as discussed in Chapter 2 (Figure 18), the enzyme was 
found to be oxygen (20) dependent with no conversion in reactions carried out in the 
glove box. This requirement for oxygen (20) was not supported by the mechanistic 
proposal. Hence, both the experimental facts invalidated the plausibility of the initial 
mechanistic hypothesis. 
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4.2 Acid-base catalyzed mechanism leading to the formation of lumichrome (12) 
Having established the roles of the individual flavins in the enzymatic 
transformation a preliminary investigation into the mechanism indicated that the reaction 
may proceed via acid-base catalysis at the C1' of riboflavin with the assistance of the 2' 
or the 3' hydroxyl groups. It was postulated that the glycosidic bond cleavage in 
riboflavin was brought about by initial redox chemistry with the cofactor NADH (22) 
and the sugar side chain (Figure 28).  
Figure 27: Mechanistic proposal for RcaE. Oxidation of the C2'-hydroxy group of riboflavin to 
ketone 76 by the oxidized nicotinamide cofactor 75 followed by the base catalyzed formation of 77 
which then tautomerizes to the corresponding imine 78. This is followed by the subsequent imine 
bond hydrolysis to give lumichrome (12) and ribose (15). 
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Figure 28: Mechanistic proposal for RcaE involving initial reduction of riboflavin (1) to 
reduced flavin (79) by NADH (22). In the next step, oxidation of the C2’-hydroxy group of 
riboflavin to ketone 80 is carried out by the oxidized nicotinamide cofactor NAD
+ 
(75). The
corresponding enol 81 then adds to a hydroxyl group by nucleophilic attack on the cofactor flavin-
hydroperoxide (27) to give intermediate 82 which then degrades to lumichrome (12) and ribose (15) 
via the formation of intermediate 83. 
The mechanistic proposal as outlined in Figure 28 involves a masked redox 
reaction with the nicotinamide cofactor. This did not agree with our observations where 
dithionite (44) was able to replace NADH (22) in the reactions indicating that the only 
role of the nicotinamide cofactor was the reduction of the flavin. Also, with the proposed 
mechanism operating, the enzyme would most likely be a metal dependant enzyme 
where the metal would be required to stabilize the ketone formed at C2'. However, no 
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metal was required in the reaction. Moreover, an ICP-MS 
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 analysis of the protein also 
revealed no metal ions bound to the enzyme. No deuterium incorporation was observed 
as well in the ribose (15) released from the reactions carried out in deuterated buffer 
(Figure 29). This suggested that no exchangeable protons were formed on the ribose 
chain during the transformation. Furthermore, the role of the hydroxyl groups of the 
sugar chain in the mechanism was conclusively ruled out by analog studies where 2'-
deoxyriboflavin (84) (Figure 30) and hydroxyethylriboflavin (85) (Figure 30) served as 
the substrates (Figure 31). The key evidence that ruled out the possibility of an ionic 
mechanism operating was obtained when lumiflavin (86) (Figure 30) was found to be a 
substrate for the enzyme (Figure 32). The above results clearly indicated that a radical 
mechanism was operating in the enzymatic transformation. 
4.3 Results 
Reaction in deuterated buffer and with substrate analogs 
No deuterium incorporation was observed in the ribose-PFBHA oxime (66) when 
the reactions were carried out with riboflavin (1) in deuterated buffer in the presence of 
PFBHA (65) suggesting the absence of exchangeable protons in the ribose side chain of 
riboflavin (1) (Fig 29). 2'-deoxyriboflavin (84) lacking the 2'-hydroxy group and 
hydroxyethylflavin (85) lacking the 3'-hydroxy were tested as substrates for the enzyme. 
Lumichrome (12) was identified as the product for both the reactions (Figure 31). Also, 
the conversion of lumiflavin (86) to lumichrome (12) was observed by HPLC analysis 
(Figure 32). These observations eliminated the possibility that the hydroxyl groups on 
the ribose played any role in the mechanism. 
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Figure 30: Structures of the flavin analogs tested as substrates for RcaE. 
Figure 29: LCMS analysis of RcaE reaction with riboflavin (1) as the substrate and reduced 
FMN (23) as the cofactor in the presence of PFBHA (65) in deuterated buffer. A: Extracted Ion 
Chromatogram (EIC) at m/z 346.07 Da to show the formation of ribose-PFBHA oxime (66) (M+H
+
346.0712) in the reaction (blue trace). 66 released from the reaction is co-eluted with a synthesized 
standard of 66 (brown trace). B: ESI-MS trace in the positive mode of the EIC peak in A (blue trace) 
showing no deuterium incorporation (no enhancement in M+2
+
 peak) in the PFBHA trapped ribose
(15) that is released from the reaction.
A 
B 
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Figure 31: RcaE reactions with 2’-deoxyriboflavin (84) and 2’-hydroxyethylriboflavin (85). 
HPLC chromatogram of RcaE reaction with substrates 84 (blue trace) and 85 (pink trace), 
showing the complete conversion of both the analogs to lumichrome (12). In both the reactions 
reduced FMN (23) serves as the cofactor. The red trace corresponds to the synthesized standard 84 
and the green trace to synthesized standard 85. 
Figure 32: RcaE reaction with lumiflavin (86). HPLC chromatogram of RcaE reaction with 86 as 
the substrate and reduced FMN (23) as the cofactor shows the complete conversion of 86 to 
lumichrome (12) (green trace). The red trace is the no enzyme control and the blue trace is the 
synthesized standard 86. 
61 
4.4 Experimental 
Synthesis of 2'-deoxyriboflavin (84) 
Procedure for the synthesis of 84 is similar to the procedure followed for the 
synthesis of cyclopropylmethylflavin (115). The NMR of the reaction intermediates are 
shown in Appendix F. 
Synthesis of N-hydroxyethylflavin (85) 
The synthetic route to the substrate analog is given in Figure 33. 
Procedure 
Synthesis of flavin-N1-carbaldehyde (89)
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To a suspension of riboflavin (5 grams, 1.35 mmoles) in 2N aqueous sulfuric 
acid (88) (130.5 mL) cooled to 0 °C in a flask covered with tin foil, sodium 
Figure 33: Synthetic scheme for N-hydroxyethylflavin (85) synthesis. 
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orthoperiodate (87) (10.4 grams, 48.5 mmoles) dissolved in 120 mL of water was added. 
The reaction was carried out on ice for 30 mins. Then the ice was removed, and the 
reaction was brought to room temperature. When the reaction became clear, the pH was 
adjusted to 3.8 – 3.9 by adding solid sodium bicarbonate. The precipitate obtained was 
washed with cold water, ethanol and diethyl ether to yield the product. Yield was 2.8 
grams (75%). Figure 34 shows the NMR of purified 89 as compared to the starting 
material riboflavin. 
Figure 34: Proton NMR of starting material riboflavin (1) (top). Proton NMR of the diol form 
of flavin-N1-carbaldehyde (89) (bottom). 
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 Synthesis of N-hydroxyethylflavin (85) 
89 (1 gram, 2.82 mmoles) was dissolved in 10 mL of dry THF in a round bottom 
flask under an inert atmosphere. Sodium borohydride (90) (189 mg, 5 mmoles) was 
added to the mixture and the reaction was stirred at room temperature for 6 hours. The 
reaction product 85 was purified by HPLC and characterized by LCMS (Figure 35). 85 
was obtained in 50% yield.  
Figure 35: LCMS trace for purified hydroxyethylflavin (85). 
Synthesis of Lumiflavin 
Lumiflavin was synthesized via following route (Figure 36).
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Figure 36: Scheme for synthesis of lumiflavin (86). 
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Procedure 
Synthesis of N-4,5-trimethyl-2-nitoaniline (93) 
Aqueous formaldehyde (92) (37%; 20 ml) was added dropwise over a period of 3 
hours to a stirred mixture of 4,5-dimethyl-2-nitroaniline (91) (500 mg; 2.7 mmol) and 
(0.01 H2SO4 (88); 20 mL). The reaction mixture was heated at 65
o
C for 3 hours, then
cooled to room temperature and poured into ice water (400 mL). The solid product was 
collected by filtration and dissolved in ethyl acetate. The solution was washed with 
saturated aqueous NaHCO3, dried over MgSO4, filtered, and evaporated to obtain the 
product 93 (yield 90%) as a red-orange solid. This compound was used in the next step 
without further purification.  
Synthesis of N-1,4,5-trimethylbenzene-1,2-diamine (95) 
Catalytic reduction of 93 was carried out with Pd/C (94) (10% Pd/C, 4% Pd w/w) 
and NaBH4 (90) (3 eqv.) in MeOH at r.t. under argon. After 40 mins the reaction mixture 
was filtered through celite using methanol as eluent. The solvent was evaporated to give 
the product 95 (Yield > 90%) which is used for the next step without further purification. 
Synthesis of lumiflavin (86) 
95 (195 mg; 1.3 mmol), alloxan monohydrate (96) (3 eqv.) and H3BO3 (97) (2 
eqv.) in 20 ml acetic acid were stirred under argon for 12 h. The fluorescent yellow 
precipitate obtained was collected by filtration and washed with acetic acid (30 ml) 
followed by ether to get the final product lumiflavin (86) in 40% yield. The proton NMR 
for 86 is shown in Figure 37.  
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Enzymatic reactions with 2'-deoxyriboflavin (84), N-hydroxyethylriboflavin (85) and 
lumiflavin (86)  
2'-deoxyriboflavin (84), N10-hydroxyethylriboflavin (85) and lumiflavin (86) 
were synthesized using the reported literature procedure. Reactions were carried out with 
250 µM of the three analogs in individual reactions with 20 µM enzyme, 20 µM FMN 
(2) and NADH (22) as the reducing agent. The reactions were incubated at 37 
°
C for 15
mins followed by filtration of the reactions using a 10 kDa cut-off filter. For 2'-
deoxyriboflavin (84) and N10-hydroxyethylriboflavin (85), the filtrate was divided into 
two parts. The first part was analyzed by HPLC to look for the formation of lumichrome 
(12). The second part was treated with pentafluorobenzylhydroxylamine (PFBHA) (65) 
at 65 
°
C for 1 hour to trap the corresponding sugars released. The solution was then
Figure 37: Proton NMR of lumiflavin (86). 
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analyzed by LCMS to look for the trapped sugar-oxime. The identities of the sugar-
oximes were confirmed by co-elution experiments with the standard oximes (Appendix 
D) which were synthesized by incubation of 2'-deoxyribose (98) and 3-hydroxypropanol
(99) with PFBHA (65) (Figures 38, 39).
Figure 38: LCMS characterization of the sugar products released from 2'-deoxyriboflavin (84) 
after treatment with PFBHA. Left trace – EIC at 330.07 Da corresponding to the M+H
+
 of 2'-
deoxyribose-PFBHA oxime (100) from the reaction (blue trace) co-eluted with synthesized standard 
of 100 (brown trace). Right trace – ESI-MS in the positive mode for the EIC trace in A showing the 
mass for 100. 
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Figure 39: LCMS characterization of the sugar products released from hydroxyethylflavin (85) 
after treatment with PFBHA. EIC at 316.04 Da corresponding to the M+H
+
 of N-
hydroxyethylflavin-PFBHA oxime (101) from the reaction (green trace) co-eluted with synthesized  
standard of 101 (blue trace). Right trace – ESI-MS in the positive mode for the EIC trace in A 
showing the mass for 101. 
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CHAPTER V 
FLAVIN DERIVED SUPEROXIDE RADICAL MECHANISM FOR RIBOFLAVIN 
DEGRADATION BY RcaE  
5.1 Introduction 
Substrate analog studies have ruled out the possibility of an acid-base mediated 
cleavage of the ribose chain of riboflavin (1) to give lumichrome (12). Here we report 
the mechanistic key points of the interesting degradation reaction. We have probed into 
the possible intermediacy of a flavin-semiquinone superoxide radical pair (Appendix C) 
in the formation of lumichrome (12) from riboflavin (1).
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It is well known in flavin dependent oxidases and oxygenases that reduced flavin 
(23) reacts with molecular oxygen (20) to form a flavinsemiquinone-superoxide radical
pair in a fast step.
15
 While in oxygenases, this radical pair then rapidly collapses to give
C4α-hydroperoxy-flavin adduct (27) (Appendix C) which participates in the oxidation of 
the substrate; in oxidases, oxidized flavin is formed directly from the C4α-hydroperoxy-
flavin adduct (27). In cryptochromes, the flavin semiquinone-superoxide radical pair 
formed during the dark re-oxidation of protein-bound flavin is responsible for 
cryptochrome derived magnetoreception.
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 CPO-coproporphyrinogen oxidase is the only
example of cofactor-independent oxygenase where a substrate derived superoxide 
radical anion (104) abstracts hydrogen atom from the substrate (102) to undergo further 
chemistry (Figure 40).
75
 So far, the only example of a flavin derived superoxide radical
(104) abstracting a hydrogen atom from a primary amine substrate (108) is the mixed
function amine oxidase (MFAO) where the superoxide radical (104) is proposed to 
69 
oxidize hydroxylamines to nitroxides 
76
 In this case the superoxide (104) abstracts a
hydrogen atom from the N-H bond resulting in a one-electron oxidation. But, the 
participation of the superoxide (104) in these systems have been proposed but have not 
been experimentally verified.
77
 Till date, there is no report in the literature of a flavin
derived superoxide radical anion (104) abstracting hydrogen from a relatively stable C-H 
bond of the substrate. For RcaE, superoxide incorporation experiments along with 
substrate analog studies support an unanticipated mechanism for a radical derived 
cleavage of riboflavin (1) to form lumichrome (12). 
Figure 40: Mechanistic proposal for the intermediacy of superoxide radical anion in 
coproporphyrin oxidase and mixed amine oxidase. 
5.2 Results and Discussions 
Non-enzymatic degradation of riboflavin by superoxide 
With the possibility of a radical mechanism operating in the enzymatic 
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transformation, the most plausible hypothesis for a radical initiator was a flavin derived 
superoxide radical anion (104). It is widely known in the literature that superoxide 
radical anion (104) is generated from oxygen (20) in the presence of riboflavin (1) 
undergoing photodegradation in air.
33,78
 This suggests that superoxide radical anion
(104) might be generated as an intermediate by the enzyme when the reduced cofactor
FMN (23) reacts with molecular oxygen (20). superoxide radical anion (104) may then 
initiate a subsequent radical reaction by H-atom abstraction at the C1' of the substrate 
riboflavin eventually forming lumichrome (12). In order to validate the hypothesis, it 
was necessary to test the non-enzymatic degradation products of riboflavin (1) when 
treated with potassium (111) superoxide.
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 When riboflavin (1) was heated with excess
of potassium superoxide (111) (Appendix G), lumichrome (12) was detected as one of 
the degradation products by HPLC (Figure 41)  
Figure 41: Non-enzymatic degradation of riboflavin (1) to lumichrome (13) and trace 
amounts of lumiflavin (86) when treated with excess potassium superoxide (111). 
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 Enzymatic reaction with superoxide 
Extending the observations of the non-enzymatic break-down of riboflavin (1) by 
superoxide (104) to the enzymatic degradation of riboflavin by RcaE, we proposed that 
the superoxide radical anion (104), formed by riboflavin (1) reacting with molecular 
oxygen (20) at the active site, further reacted with the substrate riboflavin (1) to give 
lumichrome (12). When RcaE was incubated with riboflavin (1) in the presence of 
limiting concentrations of potassium superoxide (111), formation of lumichrome (12) 
was observed in proportional amounts to the added superoxide (111). The no enzyme 
control under similar conditions generated minimal amounts of lumichrome (12) (Figure 
42A). A proportional increase in the formation of lumichrome (12) was observed with 
increasing concentrations of added potassium superoxide (111) in the presence of the 
enzyme, whereas no change in the amounts of lumichrome (12) formed was observed 
with increasing concentrations of added potassium superoxide (111) in the absence of 
the enzyme (Figure 42B). When superoxide dismutase was used as one of the 
components of the enzymatic reaction reduced amounts of the formation of lumichrome 
(12) was observed. Also, pre-incubation of the 111 with superoxide dismutase abolished
the enzyme activity (Figure 42C). These results clearly suggested that superoxide (104) 
was an intermediate in the enzymatic degradation pathway of riboflavin (1) to 
lumichrome (12) and ribose (15) by RcaE. The above experiments pointed to the fact 
that superoxide (104) could also be used as the substrate by the enzyme. 
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Figure 42: RcaE reaction with Superoxide. A: HPLC trace for the formation of lumichrome (12) 
in the RcaE reaction with riboflavin (1) as the substrate in the presence of limiting concentrations of 
external potassium superoxide (111). FMN (2) and reducing agents are absent in the reaction (blue 
trace). Slight formation of lumichrome (12) in the no enzyme control (red trace) B: HPLC the 
chromatogram showing superoxide concentration dependent formation of lumichrome (12) in the 
presence of RcaE. The increase in the formation of lumichrome (12) corresponds to the increase in 
the concentration of potassium superoxide (111) (upper set of traces) from (20 – 200) µM (20, 40, 
80, 160, 200 µM). No such increase in the formation of lumichrome (12) (lower set of traces) is 
observed with the increasing concentrations of potassium superoxide (111) in the absence of 
enzyme. C: HPLC trace for the formation of lumichrome (12) by enzymatic reaction with riboflavin 
(1) and potassium superoxide (111) only (blue trace). The red trace shows reduced formation of 
lumichrome (12) due to the addition of superoxide dismutase in the reaction. Preincubation of 
potassium superoxide (111) with superoxide dismutase followed by incubation with RcaE and 
riboflavin (green trace) shows no formation of lumichrome (12). 
A B 
C 
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Cyclopropylflavin (115) as a radical trap to detect the formation of riboflavin-C1' 
radical as an intermediate 
In the case of oxidases and oxygenases the FMN-semiquinone superoxide radical 
pair formed recombines to give flavin hydroperoxide (27) (Appendix C). However, in 
the case of RcaE, we propose that instead of recombining, the superoxide radical (104) 
in the radical pair proceeds to abstract H-atom from the C1' of the ribose chain of 
substrate riboflavin to give riboflavin-C1' substrate radical (114) (Figure 43).  
 
In order to test this hypothesis, riboflavin analog cyclopropylflavin (115) was 
designed to be used as a radical trap. In case of cyclopropylflavin (115), lumichrome 
(12) formation may proceed by two routes. In the normal route (Figure 44, Route 1) 115
may cleave to give lumichromne (12) and cyclopropylcarboxaldehyde (116). The other 
route by which 115 can be degraded by the enzyme is given by Route 2 in Figure 44. 
Here, a radical at C1' position would initiate a β-bond scission to open the cyclopropyl 
ring eventually leading to either the tagging of the side chain to the enzyme or the 
release of butanal (117) as the final product. 
Figure 43: Formation of riboflavin C1'-radical (114) 
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Figure 44: Scheme for the formation of lumichrome (2) from cyclopropylflavin (115) by two 
routes. Route1 (green) shows the formation of lumichrome (2) along with the release of 
cyclopropylcarboxaldehyde (116) as the other product which can be converted to the corresponding 
hydrazone (119) by dansylhydrazine (118). Route 2 (red) shows the formation of flavin C1' radical 
121 followed by a β-bond scission to give 122 which then can release butanal (117). The butanal is 
detected after trapping with 118 to form the corresponding hydrazone 120. 
Reactions were carried out with synthesized cyclopropylmethylflavin (115) as 
the substrate where formation of lumichrome (12) was observed (Figure 45A). No 
modification in the molecular weight of the enzyme was observed by whole protein mass 
spectrometry (Appendix H) indicating that no covalent adduct with the enzyme was 
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formed. Hence, to characterize the corresponding side chain released, the reaction was 
treated with dansylhydrazine (118) where the side chain released was trapped as the 
hydrazone and detected by HPLC (Figure 45B). No cyclopropyl-dansylhydrazone (119) 
(Appendix A) was detected in the reactions (Appendix I) whereas the two E and Z 
isomers of butanal-dansylhydrazone (120) were detected by HPLC (Figure 45B). The 
identity of 120 was confirmed by LCMS (Figure 45C) followed by co-elution with a 
synthesized standard (Figure 45D).  
Figure 45: RcaE reaction with cyclopropylflavin (115). A: HPLC chromatogram for the reaction 
of RcaE with 115 as the substrate and reduced FMN (23) as the cofactor, showing the complete 
conversion of 115 to lumichrome (12) in the full reaction (blue trace). The synthesized standard of 
115 is shown in the red trace. B: HPLC trace for the formation of the two E and Z isomers of butanal-
dansylhydrazone (120) in the reaction with 115 as the substrate, reduced FMN (23) as the cofactor in 
the presence of 118 (red trace). The blue trace corresponds to the no enzyme control. C: ESI-MS 
characterization of the 120 (M+H
+
)
 
320.14 in the positive mode. D: Co-elution of 120 generated from
the reaction with synthesized standard of 120. 
A B 
120 
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Figure 45 continued 
Figure 46: HPLC trace for the proportional increase in the formation of butanal-
dansylhydrazone (120) with increasing concentrations (5, 10, 11, 20, 40, 10 uM) of 
cyclopropylmethylflavin (115) in the reaction. The two E and Z isomers of 120 are marked by the 
arrows. The isomer (right) of 120 comes with a saturated signal and hence its corresponding increase 
cannot be detected. The third peak (red arrow) is derived from the other enzyme reaction components 
and is not related to the dansylhydrazine (118) derivatization. 
A proportional increase in the formation of butanal-dansylhydrazone (120) was 
observed with increasing concentrations of cyclopropylflavin (115) in the reaction 
C D 
120 
M = 319.1314 
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(Figure 46). The release of butanal (117) as a product from cyclopropylflavin (115) 
provided a clear evidence for the formation of a radical at C1' of the substrate flavin by 
superoxide radical anion (104) and in the course, the superoxide (104) was converted to 
a hydrogen peroxide (113). 
Comparison of the steady-state kinetic parameters of RcaE for lumiflavin (86) vs. 
cyclopropylmethylflavin (115) 
To figure out the relative rate constants for lumiflavin (86) and 
cyclopropylmethylflavin (115), initial rate plots were produced for varying 
concentrations of lumiflavin (86) and cyclopropylmethylflavin (115) in the presence of 
FRE reducing system containing FMN (2) and NADH (22) and RcaB. From the slopes 
of the initial rate plots, Michaelis-Menten plots were generated using KaleidaGraph to 
determine the kcat and the Km both for lumiflavin (86) (Figure 47) and 
cyclopropylmethylflavin (115) (Figure 48). From the steady-state kinetic data analysis 
the corresponding kinetic constants calculated are: kcat of 0.27 s
-1 + 
0.003 and a Km of
38.57 
+ 
3.55
 
µM with respect to cyclopropylmethylflavin (115) and kcat of 1.3 s
-1 + 
0.02
and a Km of 94.61 
+ 
19.22
 
µM with respect to lumiflavin (86). Though the Km of
cyclopropylmethylflavin (115) is ~2.5 time that of lumiflavin (86), the enzyme is ~ 6 
times slower with the degradation of cyclopropylmethylflavin (115) with respect to 
lumiflavin (86). The rate plots in Figure 49 gives a comparative analysis of rates of 
enzymatic lumichrome (12) formation from the same concentrations (100 µM) of 
lumiflavin (86) and cyclopropylmethylflavin (115). Rate of lumichrome (12) formation 
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is faster for lumiflavin (86) as compared to cyclopropylmethylflavin (115). Compared to 
the native substrate riboflavin (1) the enzyme is ~3.5 times slower for lumiflavin (86) 
and ~17 times slower for cyclopropylmethylflavin (115).  
Figure 47: Michaelis-Menten plot for RcaE with cyclopropylmethylflavin (115). 
 Figure 48: Michaelis-Menten plot for RcaE with lumiflavin (86). 
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Figure 49: Comparative rates of formation of lumichrome (12) by RcaE from lumiflavin (86) 
and cyclopropylmethylflavin (115). 
5.3 Experimental 
Non-enzymatic degradation of riboflavin with superoxide 
1 mM riboflavin (1) was dissolved in 5 % DMSO and was reacted with an excess 
of potassium superoxide (111). The reaction mixture was heated at 60 
o
C for 1 hour. The
resulting solution was treated with dithionite to reduce the remaining potassium 
superoxide (111) in the mixture. The solution was then analyzed by HPLC to identify the 
reaction products.  
Enzymatic degradation of riboflavin with superoxide 
50 µM of RcaE was incubated with 250 µM riboflavin (1) and ~100 µM 
potassium superoxide (111) in an reaction volume of 100 µL. Due to solubility problems 
the exact concentration of potassium superoxide (111) could not be determined. A 
similar reaction with no enzyme added was used as the control. The reactions were 
incubated for 15 mins at 37 
o
C. The reactions were filtered through a 10 kDa cut-off
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filter and analyzed by HPLC for the formation of lumichrome (12). In order to test the 
dependence of the formation of lumichrome (12) with increasing concentrations of 
potassium superoxide, five individual reactions were set up each with 250 µM riboflavin 
(1) and 50 µM RcaE. The concentration of the potassium superoxide (111) added in the
reactions ranged from 20 – 150 µM. The resulting reactions were analyzed by HPLC to 
look for a proportional increase in the formation of lumichrome (12) with the increasing 
concentrations of potassium superoxide (111) in the presence of the enzyme. As controls 
five exact reactions were set up in the absence of the enzyme and analyzed by HPLC.  
Enzyme reactions with cyclopropylflavin (115) 
250 µM of cyclopropylmethylflavin (115) dissolved in 100 mM phosphate buffer 
at pH 7.5 with 5 % acetonitrile was treated with 20 µM enzyme in the presence of 50 
µM FMN (2) and 5 mM NADH (22) and 5 mM dansylhydrazine (118). The reaction was 
incubated for 30 mins at 37 
o
C, filtered and then divided into two parts. The first part
was analyzed by HPLC to detect lumichrome (12) as one of the products. The second 
part was heated at 40 
o
C for 1 hour followed by analysis by LCMS to look for the
corresponding hydrazone (120) with dansylhydrazine (118) and butanal (117). The 
hydrazone (120) was separated as E and Z isomers on HPLC as confirmed by running a 
standard of 120 synthesized by incubating the two components in 5 % acetonitrile for 1 
hour at 40 
o
C. In order to test if the formation of the hydrazone is substrate dependent,
20, 50, 100, 200, 300, 500 µM cyclopropylflavin (115) were used as substrates for 
separate reactions following the above conditions. The corresponding hydrazone formed 
was analyzed by HPLC.  
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Synthesis of cyclopropylmethylflavin (115) 
The scheme for the synthesis of 115 is given below (Figure 50) 
Figure 50: Scheme for the synthesis of cyclopropylmethylflavin (115). 
Synthesis of tert-butyl (2-amino-4,5-dimethylphenyl)carbamate (123) 
Sodium bicarbonate (1.04 grams) was slowly added to a solution of 4,5-
dimethylbenzene-1,2-diamine (121) (680 mg; 2.8 mmoles) in 40 mL of distilled water 
resulting in a gas evolution followed by formation of a suspension. After stirring for 10 
mins, di-tert-butyl dicarbonate (122) (dissolved in 30 mL of THF) was added to the 
aqueous suspension. The resulting two phase system was stirred vigorously for 12 hours. 
The organic layer was extracted with dichloromethane and the solvent was removed by a 
rotovap. The compound obtained was purified using a silica gel column chromatography 
using chloroform/methanol as the mobile phase. The compound eluted with 4% 
82 
methanol in chloroform. Yield of 123 was 72 %. The proton NMR of 123 in D6-DMSO 
is presented in Figure 51. 
Synthesis of tert-butyl (2-((cyclopropylmethyl)amino)-4,5-dimethylphenyl) 
carbamate (126) 
370.26 mg (1.57 mmoles) of 123, 326.6 mg (6.2 mmoles) of 
cyclopropylcaboaldehyde (116) and 198 mg (3.1 mmoles) of sodium cyanoborohydride 
(125) were dissolved in 15 mL of dry methanol under stirring. The resulting solution was
refluxed at 70 °C for 48-64 hours. The solvent was removed under reduced pressure. The 
compound was obtained in pure form by silica column chromatography with 
hexane/ethylacetate gradient as the mobile phase. The compound was eluted with 15% 
Figure 51: Proton NMR for 123 in D6-DMSO. 
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ethyl acetate in hexane. The proton NMR for 126 in D6-DMSO is given below (Figure 
52) 
Figure 52: Proton NMR for 126 in D6-DMSO. 
Synthesis of (2-((cyclopropylmethyl)amino)-4,5-dimethylphenyl) carbamate (128) 
200 mg (0.68 mmoles) of 126 was dissolved in 2 mL of ethanol. 200 uL of HCl 
(127) was added to the reaction mixture and stirred for 4 hours at room temperature. The
reaction mixture was then evaporated to dryness and neutralized with saturated sodium 
bicarbonate solution. The mixture was then extracted with ethylacetate. The product 128 
obtained was further purified by a flash column chromatography with 100% chloroform. 
The NMR of 128 in deuterated methanol is given in Figure 53. 
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Figure 53: Proton NMR for 128 in deuterated methanol. 
Synthesis of cyclopropylmethylflavin (115) 
100 mg (0.52 mmoles) of 128 and 142 mg (1 mmoles) of alloxan monohydrate 
(96) was treated with 20 mg of boric acid (97) in 20 mL acetic acid. The reaction
mixture was stirred under argon for 12 hours until a fluorescent yellow precipitate was 
obtained. The solid precipitate was collected by filtration and washed with 30 mL acetic 
acid followed by washing with 30 mL diethylether. The resulting product 115 was 
further purified by silica column chromatography with chloroform/methanol as the 
mobile phase. The compound eluted with 30% methanol in chloroform. The proton 
NMR in D6-DMSO for 115 is given in Figure 54.  
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Figure 54: Proton NMR characterization of 115 in D6-DMSO. 
Kinetics of RcaE for lumiflavin (86) and cyclopropylmethylflavin (115) 
FMN (2) concentration was 50 µM and NADH (22) concentration was kept at 
saturation (5 mM) in the presence of 100 nM RcaB. The concentration of both the 
substrates was varied from 20 – 500 µM in initial rate determination reactions with 500 
nM enzyme. The formation of lumichrome (2) was quantified by HPLC using standard 
concentration curves. Reactions were carried out in 100 μL aliquots. The reactions were 
quenched at 5s, 10 s, 20 s, 30 s, 40 s, 1 min time points by denaturing the enzyme with 
0.1 N HCl. Each time-point reaction was repeated in triplicates. The amount of 
lumichrome (2) formed was plotted against the time points for each set of substrate 
concentrations. The initial slopes from each set of substrate concentrations were then 
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plotted against the substrate concentration and fit to the Michaelis−Menten equation 
using KaleidaGraph (Synergy Software). 
5.4 Conclusion 
Hint of a flavin derived superoxide radical anion mediated mechanism 
It is widely known that superoxide radical anion (104) is generated from oxygen 
(20) by SET chemistry with reduced flavins. In oxygenases the superoxide (104) is then
quenched by recombination with the flavin semiquinone (112) to give a flavin 
hydroperoxide (27). Very few examples of enzymes are known where the superoxide 
radical (104) participates in further chemistry.
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In this chapter, we propose that in RcaE, the superoxide radical anion (104), 
formed by reduced FMN (23) reacting with molecular oxygen (20) at the active site, 
further reacts with the substrate riboflavin (1) to give lumichrome (12). According to the 
mechanistic proposal (Figure 55) the superoxide radical anion (104) after its formation, 
initiates a subsequent radical reaction by H-atom abstraction at the C1' of the substrate 
riboflavin to give the riboflavin C1'-radical intermediate (114). The results in this chapter 
clearly suggest that not only is superoxide (104) an intermediate in the transformation 
but the enzyme can also use it as the substrate. 
This is extremely atypical as superoxide (104) is toxic to cells.
80
 The ErV family
Sulfhydryl oxidases are the only examples of enzymes releasing superoxide (104) into 
the cell in the extra-mitochondria locations.
17
 superoxide (104) is released during the re-
oxidation of the reduced flavin cofactor (23) generated after the oxidation of dithiol 
substrates (Figure 56). This released superoxide is proposed to act as a signaling 
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Figure 55: Flavin derived superoxide radical mediated degradation of riboflavin by RcaE. 
Figure 56: Two consecutive one-electron transfers between reduced flavin cofactor (23) and 
oxygen (20) to generate superoxide (104) in ErV family Sulfhydryl oxidases. 
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molecule. In general, to limit the concentrations of superoxide (104) in vivo the two 
superoxide degrading enzymes superoxide reductase and superoxide dismutase uptake 
superoxide (104) and convert it to less toxic species like hydrogen peroxide (113) and 
oxygen (20).
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 Apart from the two superoxide degrading enzymes, RcaE now serves as
the only other example of an enzyme which uptakes superoxide (104) directly as a 
substrate. Figure 55 presents the mechanistic proposal for RcaE consistent with the 
experimental evidences that we have obtained on the intermediacy of a flavin-
semiquinone-superoxide anion radical pair (112-104) in riboflavin (1) degradation by 
RcaE.  
Formation of riboflavin-C1' radical (114) 
In the next step we propose the participation of the FMN derived superoxide 
radical anion (104) in a subsequent one electron oxidation of the substrate riboflavin (1) 
by hydrogen atom abstraction at C1' of the sugar side chain. This will result in the 
formation of riboflavin-C1' radical (114) and hydrogen peroxide (113). Derived on the 
results obtained for the enzymatic degradation of cyclopropylmethylflavin (115), it is 
clear that the mechanism proceeds through the formation of a radical at C1' of the 
substrate flavin (114) by superoxide radical anion (104). In the ensuing steps along the 
mechanistic pathway we propose that the substrate radical (114) formed is subsequently 
oxidized to riboflavin-C1'-imine (129), donating an electron back to the reduced cofactor 
FMN-semiquinone-anion (112). The cofactor, in the course, is reduced to FMNH2 (23).  
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CHAPTER VI 
FATE OF MOLECULAR OXYGEN IN RIBOFLAVIN DEGRADATION BY RcaE 
6.1 Introduction 
In Chapter V we have provided evidence for the participation of an FMN derived 
superoxide radical anion (104) in a one-electron oxidation of the substrate riboflavin (1) 
by hydrogen atom abstraction at C1' of the sugar side chain (Figure 55). This results in 
the formation of the riboflavin substrate radical (114) and hydrogen peroxide (113). We 
propose that in a second one electron oxidation, an electron transfer from the riboflavin 
substrate radical (114) to the reduced cofactor FMN semiquinone (112) yields the 
reduced cofactor FMN (23) and the riboflavin substrate imine (129) which then reacts 
with the hydrogen peroxide (113) at the active site to give the substrate flavin-C1'-
hydroperoxide (130). The substrate hydroperoxide (130) in the consequent steps is 
converted to lumichrome (12) and ribose (15). Derived on our experimental evidence it 
is likely that the reduction of the substrate hydroperoxide (130) to hydroxide (132) is 
brought about by the reduced cofactor FMN (23) at the active site.  
The next step in the mechanism of riboflavin degradation by RcaE was to figure 
out the fate of the oxygen molecule (20) in the reaction. According to the experimental 
evidence obtained so far, it is clear that initially the oxygen molecule (20) gets converted 
to a superoxide radical anion (104) on reaction with the reduced cofactor FMN (23). The 
radical anion is then converted to a hydroperoxide anion which on protonation gives 
hydrogen peroxide (113). To figure out the fate of the hydroperoxide in the active site, 
the determination of the source of the oxygen atom in the ribose (15) formed was 
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necessary. In this chapter, we have established that the oxygen in the ribose (15) formed 
originates from molecular oxygen (20). 
6.2 Results and Discussions 
Test for the release of hydrogen peroxide by oxygen electrode experiments 
According to the experimental evidences obtained so far, it is clear that initially a 
superoxide radical anion (104) is formed when molecular oxygen reacts with the reduced 
cofactor FMN (23). The radical anion (104) is then converted to a hydroperoxide anion 
which on protonation gives hydrogen peroxide (113). The release of 113 in turn, can be 
analyzed by Clarke electrode after treatment of the reaction mixture with catalase.
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 In
order to test the calibration of the oxygen electrode instrument, aerobic buffer with a 
dissolved oxygen (20) concentration of 260 µM was diluted 1.2 times with anaerobic 
buffer to get a corresponding 44 µM decrease in the oxygen concentration (Figure 57).  
Figure 57: Calibration of the oxygen electrode instrument. 
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In order to figure out if any hydrogen peroxide (113) is released from the 
reaction, the reaction mixture was treated with catalase and oxygen electrode was used 
to detect the formation of any oxygen (20). Figure 58 shows the results of the oxygen 
electrode experiments, where stoichiometric amounts of photo-reduced FMN (23) was 
added to a mixture of riboflavin (1) and the enzyme in an oxygenated buffer containing 
260 µM oxygen (20) (Segment A) to get an equivalent amount of oxygen (20) 
consumption (CO2 Segment [A – B]). On addition of catalase to the system, no oxygen 
(20) production was observed (CO2 Segment [C-B]) indicating that hydrogen peroxide
(113) is not a product of the reaction. (CO2 Segment [D-C]) is the control that shows the
production of oxygen (20) on addition of external hydrogen peroxide (113) solution to 
the system.  
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riboflavin (1) to lumichrome (12) in the presence of reduced FMN (23). The slight increase in the 
oxygen (20) concentration in Segment C compared to Segment B is due to the concentration factor 
when 50 µL of catalase in buffer with an oxygen (20) concentration of 260 µM is added to 550 µL of 
the reaction mixture in Segment B with an oxygen (20) concentration of 62 µM. Segment C 
corresponds to the oxygen (20) concentration in the system after catalase addition. The increase in 
oxygen (20) concentration in Segment D compared to Segment C is due to the generation of half 
equivalent of oxygen (20) when 50 µL of 150 µM external hydrogen peroxide (113) is added to 
Segment C. Segment D corresponds to the oxygen (20) concentration in the system after external 
hydrogen peroxide (113) addition.
Figure 58: Oxygen Electrode analysis of RcaE reaction with the native substrate under single 
turnover conditions. Segment A represents the oxygen (20) concentration in air-saturated buffer in 
the presence of enzyme and riboflavin (1). The decrease in the concentration of oxygen (20) from 
Segment A to Segment B corresponds to the stoichiometric consumption of oxygen (20) with respect 
to the concentration of reduced FMN (23) added in Segment A. Segment B corresponds to the 
oxygen (20) concentration in the system after the consumption of oxygen (20) by RcaE to convert 
riboflavin to lumichrome (13) in the presence of reduced FMN. The slight increase in the
oxygen concentration in Segment C compared to Segment B is due to the concentration factor
when 10 µL of catalase in buffer with an oxygen concentration of 260 µM is added to 110 µL of
the reaction mixture in Segment B with an oxygen concentration of 62 µM. Segment C
corresponds to the oxygen concentration in the system after catalase addition. The increase in
oxygen concentration in Segment D compared to Segment C is due to the generation of half
equivalent of oxygen when 10 µL of 110 µM external hydrogen peroxide is added to Segment
C. Segment D corresponds to the oxygen concentration in the system after external hydrogen
peroxide addition.
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Figure 59 shows the graph for the enzymatic reaction where the catalase was 
added from the beginning. It shows the similar results as in Figure 58. As control 
experiment, the oxidation of reduced FMN (23) in the presence of the enzyme was 
studied (Figure 60). In Segment B, a release of hydrogen peroxide (113) was detected by 
the increase in oxygen (20) concentration in the presence of catalase added in Segment 
A. Segment C shows that the catalase in the reaction mixture is active to the externally
added hydrogen peroxide (113). 
Fate of molecular oxygen (20) in the enzymatic transformation 
The detection of the source of the oxygen in the ribose (15) was technically demanding. 
Firstly, the oxygen in the ribose is lost when trapping agents like hydroxylamine or 
hydrazine are used to trap the ribose. Finally, as the oxygen is incorporated as an 
aldehyde, it is easily exchangeable with the solvent. Hence, in order to trap the oxygen 
in the ribose in a form that it can be identified, a coupled reaction was devised (Figure 
61) where the released ribose (15) was first converted to ribose-5-phosphate (24) by
ribose kinase (Rbks) followed by the conversion of the 24 to ribulose-5-phosphate (133) 
by ribose-5-phosphate isomerase (Rpi).
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 133 can be trapped with PFBHA (65) to form
ribulose-5-phosphate-PFBHA oxime (134). Due to the reversibility of ribose-phosphate 
isomerase, ribose-5-phosphate-PFBHA oxime (67) was also expected to be formed as 
one of the products. In ribulose-5-phosphate-PFBHA oxime (134), the oxygen at the 5' 
position will be trapped in the form of a non-exchangeable hydroxyl group and can thus 
be analyzed for 
18
O incorporation by LCMS in a reaction using 
18
O labeled molecular
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oxygen (20). In contrast, there will be no incorporation of the 
18
O label in ribose-5-
phosphate-PFBHA oxime (67).   
Figure 59: Oxygen Electrode analysis of RcaE reaction with the native substrate under single 
turnover conditions. Segment A represents the oxygen (20) concentration in air saturated buffer 
where enzyme, riboflavin (1) and catalase are present. The decrease in the concentration of oxygen 
(20) from Segment A to Segment B corresponds to the stoichiometric consumption of oxygen (20) 
with respect to the concentration of reduced FMN (23) added in Segment A. Segment B corresponds 
to the oxygen (20) concentration in the system after the consumption of oxygen by RcaE to convert 
riboflavin (1) to lumichrome (12) in the presence of reduced FMN (23). The increase in oxygen (20) 
concentration in Segment C compared to Segment B is due to the generation of half equivalent of 
oxygen (20) when 50 µL of 150 µM external hydrogen peroxide (113) is added to Segment B. 
Segment C corresponds to the oxygen (20) concentration in the system after external hydrogen 
peroxide (113) addition. 
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Figure 60: Oxygen Electrode analysis of RcaE reaction in the absence of the substrate 
riboflavin (1). Segment A represents the oxygen (20) concentration in air saturated buffer where 
enzyme and catalase are present. Segment B corresponds to the oxygen (20) concentration in the 
system after the consumption of oxygen (20) by reduced FMN (23) to form oxidized FMN (2). 
Segment C corresponds to the oxygen (20) concentration in the system after the evolution of 
oxygen (20) from catalase in the presence of added external hydrogen peroxide (113). 
96 
Reaction in 
18
O2 (20a) to look for incorporation of molecular oxygen in the ribose (15)
formed 
Coupled reactions of RcaE with ribose kinase and ribose phosphate isomerase 
were carried out in 
18
O2 (20a) with riboflavin (1) as the substrate. The product of the
coupled reaction ribulose-5-phosphate (133) was trapped with PFBHA (65) to give 
ribulose-5-phosphate-PFBHA oxime (134), which stayed in equilibrium with the ribose-
5-phosphate-PFBHA oxime (67). From the LCMS analysis (Figure 62), the peak for EIC
at 426 corresponding to the exact mass of both ribose-5-phosphate-PFBHA oxime (67) 
and ribulose-5-phosphate-PFBHA oxime (134) also had a mass at m/z 428 when 
Figure 61: Scheme for the coupled reaction to show incorporation of 
18
O in ribose released
from the RcaE reaction. 
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analyzed by ESI-Mass spectrometry in the positive mode, thereby indicating the 
incorporation of an oxygen molecule from 
18
O2 into the 5-membered sugar (Figure 62A).
From the mass mass spectrometric analysis, no 
18
O incorporation was found in ribose-5-
phosphate-PFBHA oxime (67) (Figure 62B) whereas ~60% 
18
O incorporation was found
in the ribulose-5-phosphate-PFBHA oxime (134) (Figure 62C). This experiment 
provided evidence for the incorporation of molecular oxygen at the C1' of riboflavin to 
give lumichrome (12) and the sugar aldehyde.  
Stoichiometric formation of lumichrome (12) with reduced FMN (23) 
The graph in Figure 63 represents an equivalent formation of lumichrome (12) 
with the addition of reduced FMN (23) to the reaction in the presence of excess substrate 
riboflavin (1) and enzyme. A crystal structure of the substrate and cofactor bound 
enzyme will reveal the active site conformations of the substrate, cofactor, and oxygen, 
which is currently under way.  
B C 
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Figure 62: LCMS analysis of the coupled reaction of RcaE, Ribokinase, Ribosephosphate 
isomerase with riboflavin (1) as the substrate and reduced FMN (23) as the cofactor in 
18
O2
(20a) in the presence of PFBHA (65). A: Extracted Ion Chromatogram (EIC) at m/z 426.04 
corresponding to M+H
+
 of both ribose-5-phosphate-PFBHA oxime (67) (left peak) and ribulose-5-
phosphate-PFBHA oxime (134) (right peak) to look for the formation of both the species in the 
coupled reaction. B: ESI-MS analysis in the positive mode for 67 showing no 
18
O incorporation. C: 
ESI-MS analysis in the positive mode for 134 showing 60% 
18
O incorporation.
B C 
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6.3 Experimental 
Oxygen electrode experiment 
For the experiment presented in Figure 58, 150 µL of 150 µM photo-reduced 
FMN (23) in anaerobic buffer was added to 350 uL of aerobic buffer containing 150 µM 
of enzyme and 125 µM riboflavin (1) in Segment A. In the segment B the signal 
stabilized at 62 µM. This was followed by the addition of 50 µL of 20 units of catalase 
to achieve a final concentration of 91 µM oxygen in Segment C. 50 µL of 150 µM H2O2 
(113) was added to the reaction mixture to get a final concentration of 190 µM oxygen
(20) in Segment D. For the experiment in Figure 59, similar conditions as in Figure 58
were used with the difference that the 20 units of catalase was added in the start at 
Segment A. In the next experiment (Figure 60), to 150 µM of enzyme in the presence of 
20 units of catalase (Segment A), 150 µM of photoreduced FMN (23) was added to get 
Figure 63: Stoichiometry of the formation of lumichrome (12) with added reduced FMN (23). 
Stoichiometric formation of lumichrome (12) (Y-axis) with each addition of 10 µM photoreduced 
FMN (23) after an interval of 5 mins in the presence of excess RcaE and riboflavin (1). The amount 
of lumichrome (12) formed decreases with the addition of increasing amounts of photoreduced FMN 
(23) due to the competing auto-oxidation reaction of reduced FMN (23).
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an oxygen (20) concentration of 120 µM in Segment B. To this 50 µL of 100 µM 
hydrogen peroxide (113) was added to get an oxygen (20) concentration of 220 µM in 
Segment C.  
Cloning, overproduction, and reconstitution of recombined His-tagged ribose-
phosphate isomerase (RpiA)  
The rpiA gene was amplified by PCR using genomic DNA of E.coli K12 as the 
template (F primer: 5'-AA CATATG ACGCAGGATGAATTG-3', R primer: 5'-AA 
GAATTC AGA TTTCACAATGGTTTTGACAC-3', engineered NdeI and EcoRI site are 
in italics). The PCR product was digested with NdeI and EcoRI and ligated into pET28b 
(NdeI/EcoRI digested backbone) to generate the plasmid pXH-2. The plasmid was 
transformed into BL21 (DE3). Resulting transformants were grown in 3 L of LB 
medium with 40 μg/mL of kanamycin at 37 °C to an OD600 of 0.5 IPTG was added to a 
final concentration of 0.4 mM and incubation was continued at 15 °C for 18 hours. The 
His-tagged RpiA was purified on a HisTrap HP column (GE) and buffer-exchanged into 
50 mM KH2PO4, 300 mM NaCl, 10% glycerol, pH 7.5 by passing through an Econo-Pac 
10DG desalting column (Bio-rad). The protein was flash-frozen in liquid nitrogen and 
stored at -80 °C. For enzyme reconstitution, a reaction mixture (100 μL) of 20 μM RpiA 
and 250 μM ribose-5-phosphate was incubated at 37 °C for 15 mins. Protein was 
removed by ultrafiltration (10 kDa cut-off filter) and the reaction mixture was analyzed 
by HPLC followed by LC-MS. 
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Coupled reaction with 
18
O2
A 100 uL reaction containing 250 µM riboflavin (1), 200 µM photoreduced FMN 
(23) and 10 mM ATP (21) was mixed with an enzyme cocktail containing 10 µM RcaE,
20 µM ribokinase, 20 µM  ribosephosphate isomerase in an eppendorf tube. The 
eppendorf tube was placed in a 10 mL round-bottom flask and was made anaerobic by 
incubation in the glove box for 2 hours. Then the mouth of the flask was sealed with a 
rubber stopper and parafilm and the setup was brought outside the glove box. To start 
the reaction, a balloon containing 
18
O2 (20a) was purged into the flask. The setup was
incubated for 10 mins at 37 
o
C. The enzymes in the reaction were removed by filtration
through a cut-off filter, and the reaction was incubated with PFBHA (65) at 37 
o
C for 1
hour. The resulting reactions were analyzed by LCMS to look for 
18
O incorporation in
the ribulose-5-phosphate oxime (134). The different sets of reactions including the 
control reactions carried out are shown in Table 4. 
Table 4: Reaction conditions for the coupled reaction with RcaE, RcaD and RpiA 
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6.4 Conclusion 
No detection of released hydrogen peroxide (113) in the reaction mixture by 
Clark electrode (Figure 58) was suggestive of the involvement of the hydrogen peroxide 
(113) in the later steps of the mechanism. A likely fate of the hydroperoxide ion at the
active site can be its incorporation at the C1' of the substrate flavin imine (129) (Figure 
55). For this possibility to hold true, the oxygen atom in the ribose (15) released had to 
come from molecular oxygen (20). Indeed, in the coupled reactions with 
18
O2 (20a), a
60% incorporation of 
18
O into the released ribose (15) was observed.
As discussed in the previous chapter (Chapter V), the formation of the flavin 
imine (129) was attributed to the reaction between the flavin derived superoxide radical 
(104) with the C1' position of riboflavin (1). Here, we propose that in next step, the
flavin imine (129) reacts with the hydrogen peroxide (113) in the active site to give the 
corresponding flavin-hydroperoxide (130) (Figure 55). Further conversion of the 130 to 
the flavin hydroxide (132) is proposed to be mediated by the reduced cofactor FMNH2
(23) at the active site. According to our mechanistic hypothesis, 23 steps in and reduces
the substrate flavin-hydroperoxide (130) to the corresponding hydroxide 132 via the 
intermediacy of flavin-4α-hydroxide (131). Finally the flavin-4α-hydroxide (131) 
releases a water molecule to get converted to oxidized flavin (2). This makes FMN (2) 
the end product of the reaction and hence the reduced cofactor is not regenerated in the 
enzymatic transformation. Thus the requirement of FMN in the reaction must be 
stoichiometric. Indeed, the degradation of riboflavin by RcaE was found to be 
stoichiometric with respect to the concentration of photoreduced FMN (23) (Figure 63). 
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The other possible route for the reduction of 130 to 132 is via the intermediacy of the 
recently discovered flavin N5-oxide species.
84-86
 In this system, we propose the
formation of a reduced FMN-N5-oxide (28) which may then release a water molecule 
and get converted to oxidized flavin (FMN) (2) (Figure 64).   
Figure 64: Scheme for reduced FMN-N5-oxide mediated cleavage of flavin hydroperoxide 
intermediate (130). 
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CHAPTER VII 
STEREOCHEMICAL STUDIES OF RcaE WITH ISOTOPICALLY ENRICHED 
DEUTERATED RIBOFLAVIN  
7.1 Introduction 
The stereochemistry of hydrogen abstraction at C1' of riboflavin (1) can be 
predicted by either solving the crystal structure of RcaE bound to the substrate or from 
stereochemical studies with isotopically labeled riboflavin analogs. In the event of a low 
resolution crystal structure, knowing the stereochemistry of the hydrogen abstraction by 
biochemical studies will help us predict the relative orientation of the substrate and 
cofactor at the active site. The stereochemistry of the hydrogen abstraction can be 
determined from the ratio of the unlabeled vs. the monodeuterated ribose formed when 
the C1'-deuterated riboflavin (135) analog enriched at the R or S is incubated with the 
enzyme (Figure 65).  
Figure 65: Fate of the D label in the oxime formed from D-labeled riboflavin (135). 
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Also, the residues responsible for binding the two flavins at the active site have 
been predicted by bioinformatic analysis of the conserved domains for RcaE using the 
Uniprot database (Figure 66). 
 
7.2 Abstraction of pro-R hydrogen from C1' position of riboflavin 
When a 3:1 mixture of C1'-S-D-riboflavin : C1'-R-D-riboflavin was incubated 
with the enzyme in the presence of PFBHA (65), formation of the unlabeled ribose-
PFBHA oxime (66) : D-ribose-PFBHA oxime (66a)was observed in ~ 1 : 3 ratio (Figure 
67). This clearly suggested that the enzyme preferentially picks up the pro-R hydrogen 
from the C1' position of D-riboflavin. To re-establish the results, a 3:1 mixture of C1'-R-
D-riboflavin  :  C1'-S-D-riboflavin was incubated with the enzyme in the presence of 65. 
In this case the ratio of unlabeled ribose-PFBHA oxime (66) : D-ribose-PFBHA oxime 
(66a) formed was  ~ 3 : 1. This established that the pro-S hydrogen is not abstracted in 
Figure 66: Predicted residues responsible for binding the two flavins at the active site of RcaE. 
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the transformation. A clear picture of the stereochemical orientation of the substrate in 
the protein active site will be obtained with a crystal structure having the substrate bound 
to the active site. 
 
Enzymatic reaction with R and S C1'-D riboflavin 
7.3 Enzymatic reaction with R and S C1'-D riboflavin (133) 
In two different sets of enzymatic reactions, 250 µM R/S C1'-D riboflavin was 
incubated with 20 µM FMN in the presence of 5 mM NADH and 50 µM RcaE. The 
reactions were incubated for 10 mins followed by incubation with 2 mM PFBHA (65) at 
A 
B 
Figure 67: Detection of the formation of both non-labeled and D-labeled ribose-PFBHA from 
the S and R isomers of C1'-D-riboflavin (135). A: Formation of unlabeled : D-labeled ribose-
PFBHA in ~ 3 : 1 ratio from C1'-D-riboflavin using 75% of C1'-R-D-riboflavin. B: Formation of 
unlabeled : D-labeled ribose-PFBHA in ~1 : 3 ratio from C1'-D-riboflavin using  75% of C1'-S-D-
riboflavin.
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65°C for 1 hour. The resulting solution was analyzed by LCMS to analyze for D-
incorporation in the ribose-PFBHA oxime formed in the reaction mixture. 
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CHAPTER VIII 
CRYSTAL STRUCTURE DETERMINATION OF RcaE 
8.1 Introduction 
The biochemical evidences obtained on the mechanism of RcaE indicate the 
participation of a flavin derived semiquinone radical (104) in the abstraction of hydrogen 
from the C1' of riboflavin (1). Also, stereochemical experiments indicate that the pro-R 
hydrogen at C1' is abstracted in the transformation. In order to get a better idea of the 
stereochemistry of the reaction, a crystal structure determination of the enzyme will be 
helpful. Also, it will show us the relative orientations of the substrates at the active site 
thereby validating our previous biochemical studies. Initial attempts to obtain a crystal 
structure with RcaE with the bound reduced cofactor FMN (23) were unsuccessful. 
Since the enzyme binds to reduced FMN (23) it was challenging to obtain protein 
crystals under aerobic conditions. Hence, an FMN analog, 5-deazaFMN (72) was 
designed to use for co-crystallization with RcaE. Due to the replacement of nitrogen 
with a carbon at the 5 position, reduced 5-deazaflavin is incapable of aerial oxidation 
involving an SET mechanism with molecular oxygen. Further approaches adopted to 
obtain the crystal structure was to use orthologs of RcaE, and also try out the truncated 
version of the protein developed by alignment to the nearest neighbor with a crystal 
structure, LadA – the long chain alkane monooxygenase which in Geobacillus 
thermodenitrificans converts  long-chain alkane to corresponding primary alcohols.
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8.2 Results and Discussions 
Purification of RcaE for crystal screen experiments 
RcaE was purified using the regular purification procedure for His-tagged 
proteins. Next, the histidine tag was cleaved from the protein using TEV protease that 
cleaved at the TEV cleavage site located between the protein sequence and the His-tag 
sequence. This was followed by a round of purification through a Ni-NTA column to get 
rid of the histidine tag and the His-tagged TEV. Figure 68A shows the pure band of His-
tag cleaved RcaE after purification. The eluent from the column consisted of the pure 
His-tag cleaved RcaE. For further purification, the tag cleaved protein was passed 
through a size exclusion column to obtain a predominant single band at 12.5 mins 
corresponding to the monomer of RcaE (Figure 68B).  
A 
B 
Figure 68: Purification of RcaE for crystallization. A: Purified RcaE after His-tag cleavage. B: 
RcaE after elution through a size-exclusion column. 
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Crystallization of RcaE 
From binding studies reported in Chapter III it is evident that the cofactor FMN 
binds to the enzyme only in its reduced form. This activates the enzyme for binding with 
the oxidized substrate riboflavin (1). However, in order to get a crystal structure of RcaE 
bound to the cofactor, reduced FMN (23) cannot be used due to its fast rate of oxidation 
under aerobic conditions. To circumvent the problem, 5-deazaFMN (72) was chemically 
synthesized and reduced with dithionite (44). Due to the absence of the pyrazine ring this 
reduced form of 5-deazaFMN (72) would not undergo aerial oxidation and would thus 
remain bound to the enzyme in its reduced form throughout the entire duration of 
crystallization. Four different set ups were used for crystallization (Table 5). Set 1 and 
Set 2 were set up for crystallization of apo-protein in the absence and in the presence of 
the reducing agent dithionite, respectively. In Set 3, the enzyme incubated with reduced 
cofactor 5-deazaFMN (72) was set up for crystallization. Set 4 consisted of the enzyme 
bound to reduced cofactor 5-deazaFMN (72) and substrate riboflavin (1). The 
crystallization was set in 96-well plates with different types and concentrations of 
precipitants and salts using the sitting-drop vapor diffusion method. Eleven 96-well 
plates were set up for the crystal screen that include 3 different salt screens (WIZARD 
and SRX) containing different salts and buffer at different pH; 6 lab screens (LS, CS, 
IMEX) containing salt, buffer and different types and concentrations of precipitants; 2 
screens (PI and IND) containing different types of salt with different concentrations of 
the precipitant PEG. After 2-4 weeks, transparent crystals were obtained in some of the 
conditions, but all the crystals were found to be salt crystals. This indicated that the full 
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length RcaE from the Microbacterium species may not be suitable for crystallization. 
Thus, in anticipation of solving the problem, crystallization trials were set up using the 
truncated version of RcaE where the flexible N-terminal and C-terminal ends were 
predicted by the software Phyre2 using the already solved crystal structure of LadA 
bound to FMN (PDB - 3B9O).
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 Also 5 different orthologs of RcaE from 5 organisms
were tested for crystallization.  
Table 5: Conditions for crystallization of RcaE. 
Crystallization of the truncated enzyme 
 LadA is the closest member to RcaE with a 40% sequence similarity for which 
the crystal structure has been solved. The sequence of RcaE was aligned to the sequence 
of LadA and using the software Phyre2, the flexible regions of RcaE were predicted. 
These regions form hanging loops, hence likely to hinder protein crystallization. Phyre2 
uses the alignment of hidden Markov models via HHsearch
1
 to significantly improve
accuracy of alignment and detection rate. Next, it incorporates a new ab initio folding 
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simulation called Poing
2
 to model regions of the protein of interest with no detectable
homology to known structures. From the results, the flexible regions were at the N-
terminal and C-terminal regions of RcaE (Figure 69). This made the truncation easier as 
the core of the protein would remain intact after truncation. The truncation was achieved 
by a subcloning strategy where the gene was cloned from pTHT by designing primers 
with restriction site absent in pTHT but present in a second vector pGEM7. Then, 
restriction digestion of the gene of interest was carried from pGEM7 using restriction 
sites common to both pTHT and pGEM7 followed by re-cloning into pTHT vector. The 
resulting plasmid was then isolated, purified and sequenced to confirm the truncation. 
Crystallization screens were set with the truncated protein following the same conditions 
as the native protein.  
Figure 69: The sequence of RcaE with the underlined flexible N and C terminal sequences. 
The red sequences constitute parts of α-helix and the blue sequences constitute parts of β-sheets. 
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Design, overexpression and purification of RcaE orthologs for protein crystallization 
The sequence similarity network for RcaE was obtained by NCBI protein 
psiBLAST. Orthologs of RcaE were initially selected derived on > 95 % sequence 
coverage and a high (> 60 %) sequence identity (Table 6). The next criterion used to 
shortlist suitable targets was to check if the orthologs had neighboring functional genes 
similar to RcaE responsible for riboflavin catabolism (Table 7). Such a comparison for 
the neighboring genes of the orthologs from Kitasatospora setae is shown in Figure 70. 
Finally, five orthologs from Herbiconiux sp., Marine actinobacterium, Devosia 
riboflavin, Leifsonia aquatic and Kitasatospora setae were selected as targets for 
crystallization. 
Table 6: Bioinformatic analysis of the RcaE orthologs 
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Table 7: List of functional genes (marked in red) in the gene cluster containing RcaE 
Figure 70: The genes neighboring RcaE ortholog in Kitasatospora setae and their similarity 
genes in the RcaE gene cluster. 
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The five orthologs of RcaE were gene synthesized from Genscript, cloned into 
pTHT vector, overexpressed in BL21-DE3 cells and purified by Ni-NTA column 
chromatography as described earlier (Figure 71A). For the His-tag cleavage the proteins 
were treated with TEV protease and purified by NI-NTA column chromatography. The 
tag cleavage and purification of the orthologs from Kitasatospora setae (Ortholog 2) is 
shown in Figure 71B.  
 
 
Test for enzyme activity of the purified RcaE orthologs and truncated RcaE 
The following experiments were done to test the riboflavin lyase activity of the 
RcaE orthologs. 
   50 kDa 
Figure 71: Purification of the five RcaE orthologs for crystallization. A: SDS-PAGE gel 
analysis of purified RcaE orthologs from five different microorganisms. B: SDS-PAGE gel analysis 
of RcaE ortholog from Kitasatospora setae after his-tag cleavage and further purification. 
A B 
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• Enzyme converts riboflavin (1) to lumichrome (12) and ribose (15) (Figure 72)
• Lumiflavin (86) acts as the substrate to indicate radical chemistry (Figure 73)
• FMN is used as the cofactor (Figure 74)
• Reduced 5-deazaFMN (72) binds to the enzyme to make sure that the analog is
suitable for crystallization experiments
• Same studies with the truncated protein
Enzymatic reactions were set up using the different substrates and cofactors
listed in Table 8.
Table 8: The list of the different substrates and cofactors used for the enzymatic reactions 
of RcaE orthologs. 
Figure 72A shows the HPLC trace for the reconstitution of the 5 orthologs of 
RcaE and the truncated RcaE with riboflavin as the substrate and reduced FMN (23) as 
the cofactor. All the orthologs give almost complete conversion of riboflavin (1) to 
lumichrome (12) in 30 minutes. Figure 72B is the representative for the control reactions 
performed with the orthologs. It includes the reaction results in the absence of individual 
reaction components for the Ortholog 2. The release of ribose (15) as the other reaction 
product was tested for the orthologs by LC-MS. 
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Figure 72: Reconstitution of RcaE orthologs. A: HPLC trace for the formation of lumichrome (13) 
for the 1 RcaE orthologs and truncated RcaE. B: The control reactions for the Ortholog 2 whre FMN, 
enzyme and NADH are absent in three different reactions. 
Figure 73: Reconstitution of RcaE orthologs and truncated RcaE with lumiflavin as the 
substrate and reduced FMN as the cofactor. 
A 
B 
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The next set of experiments was carried out to establish the role of FMN as the 
cofactor. As discussed in Chapter III 5-deazaFMN (72) and 5-deazariboflavin (73) were 
used in the reactions. As expected no lumichrome (12) formation was observed when 5-
deazaFMN (72) and riboflavin (1) were incubated with the enzymes in the presence of 
dithionite (44). In contrast, 5-deazariboflavin (73) was converted to 5-deazalumichrome 
(74) in the enzymatic reaction in the presence of FMN (2) and dithionite (44) (Figure
74). The reaction was much slower for Ortholog 4 and required incubation for 4 hrs. 
Figure 74: Reconstitution of RcaE orthologs with reduced FMN (23) as the cofactor and 5-
deazariboflavin (73) as the substrate. 
8.3 Experimental 
Crystal screen set-up for the RcaE orthologs 
Crystallization plates were set up in 96-well plate format for the five orthologs of 
RcaE and the truncated RcaE using sitting-drop vapor diffusion method. The 
crystallization solutions were used as described before. Bright yellow crystals were 
obtained for Ortholog 5 (Herbiconiux sp.) in 8 different crystal solutions (Table 9). The 
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conditions marked in red in the table were used for further optimization of the crystals. 
Initial X-ray diffraction with the crystals provided diffraction patterns consistent with 
protein crystals. But, the resolution of the diffraction data was extremely poor (Figure 
75). 
Table 9: The mother liquor composition for crystal formation with Ortholog 5. 
Figure 75: Diffraction pattern obtained from the crystal of RcaE ortholog from Herbiconiux sp. 
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Optimization for conditions for crystallization of RcaE orthologs from Herbiconiux sp. 
The crystals were further refined using hanging drop method in 24-well plates. 
Taking the initial solution composition as the starting point, both pH and concentration 
of the salts were varied along the X and Y axes of the 24-well plate. The modified 
solvent compositions for the two different screening solutions selected are shown in 
Figure 76. For each screening solution, four 24-well plates were used for optimization 
with different concentrations of the components and different pH.  
Figure 76: Crystal screen solutions selected for the optimization of RcaE orthologs crystals. 
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Within 3 weeks of setting up the crystals, long, beautiful rod shaped bright 
yellow crystals were obtained in the solution with 1.8 – 2.0 M ammonium sulfate and 
0.1 (M) Bis-Tris at pH 5.8 – 6.2. 
Enzyme purification by TEV protease cleavage followed by size-exclusion 
chromatography 
The enzyme RcaE (and its orthologs) obtained after desalting was incubated with 
TEV enzyme. The concentration of TEV is maintained such that it undergoes 5 
turnovers to cleave the tag in the enzyme. The enzyme was incubated with TEV at room 
temperature for 4 hours followed by incubation at 4˚C for overnight. The mixture was 
then passed through a Ni-NTA column and the pure enzyme was eluted with 100 mM 
phosphate buffer at pH 8.0. The TEV and the histidine tag remained bound to the 
column. Small aliquots of samples from before and after TEV cleavage, as well as from 
the following purification process were run on an SDS-PAGE gel and compared for 
analysis of cleavage-efficiency and purity.  
Cloning and overexpression of truncated RcaE 
The protocol followed to clone the truncated RcaE is shown in Figure 77. The 
primers used for the cloning are also listed in the figure. 
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Figure 77: The forward and reverse primers for cloning truncated RcaE into pTHT vector 
(top). The protocol followed to obtain the truncated truncated RcaE (bottom). 
Enzymatic reactions of the RcaE orthologs 
250 µM of the substrate was incubated with 20 µM enzyme in the presence of 20 
µM cofactor and 2 mM NADH (22). All reactions were incubated at 37°C for 30 mins. 
8.4 X-ray diffraction data for the crystal of RcaE ortholog 
The X-ray diffraction data will be obtained for the crystals of RcaE ortholog 
from Herbiconiux sp. Data was collected at the Advanced Photon Source (Argonne, 
Illinois, USA)-1 Å (wavelength) a at beamline 24ID-C using a Pilatus 6 M pixel detector 
at a temperature of 100 K. X-ray Diffraction data were collected  for 360 frames. Data 
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sets were integrated in HKL2000 to obtain the unit cell dimensions. Next, the space 
group was determined from the systematic absences by Xtriage (PHENIX) to be P212121  
(orthorhombic space group). Phasing was achieved by PHENIX software using 
Molecular Replacement method. The crystal structure of LadA bound to FMN (PDB 
3B9O) with a 40 % sequence similarity with RcaE was used for homology modeling. 
Following this, an electron density map was generated and fit to individual residues. 
Further rounds of refinements revealed a positive density corresponding to 5-deazaFMN 
(72). A faint density for the other flavin ring was observed but the density was not 
enough to build a structure. This might have been due to the poor solubility of riboflavin 
(1) in comparison to the phosphorylated flavin 5-deazaFMN (72).
8.5 X-ray crystal structure of RcaE ortholog from Herbiconiux sp. 
A crystal structure of the RcaE ortholog with a resolution of 2.12 Å was 
obtained. The Rwork was 0.22 whereas the Rfree was 0.25. The protein crystallized as a 
dimer (Figure 78). The active site on each monomer is present near the surface. One of 
the monomers had 5-deazaFMN (72) bound to the active site. Figure 79 shows the 
Rossmann fold with 6 alternate α-helices and β-sheets at the active site of the monomer 
housing the 5-deazaFMN (72).  
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Figure 78: Crystal structure of the dimer of RcaE ortholog from Herbiconiux sp. with 5-
deazaFMN (72) bound at the active site 
 Figure 79: Rossmann fold in the crystal structure of the monomer of RcaE ortholog A: 6 
alternate a-helices and b-sheets forming the Rossmann fold. B: Top view of the Rossmann fold 
housing the cofactor 5-deazaFMN (72) 
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A zoom in to the active site reveals the active site residues responsible for the 
binding of the cofactor (Figure 80A). His155, Ser230 and Try159 stabilize the phosphate 
group of the 5-deazaFMN (72). One of the oxygen from the phosphate group stabilizes 
the C3'-hydroxyl group by hydrogen bonding. Also, the N1 of the flavin ring interacts 
with the C2'-hydroxyl group. Hence, there is a stabilized tight binding pocket for the 
ribose-phosphate group of the cofactor at the active site. The other interactions are 
Asp59 with N3 and Asn134 with the C5 (originally a nitrogen in the cofactor FMN (2)). A 
π-stacking interaction of the flavin ring with Phe245 is observed (Figure 80B). There are 
two conspicuously placed Phe residues (Phe11 and Phe56) that might orient themselves 
once the substrate is bound to intercalate the flavin ring.  
Figure 80: Interaction of the active site residues with the cofactor 
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CHAPTER IX 
SUMMARY, CONCLUSION AND FUTURE PERSPECTIVE 
9.1 Summary 
In this thesis, a mechanistic proposal for the oxidative degradation of riboflavin 
by riboflavin lyase consistent with the experimental results obtained from substrate 
analog and isotope labeling experiments has been proposed (Figure 55 reproduced). 
Figure 55 (reproduced): Mechanistic scheme for riboflavin degradation by riboflavin lyase. 
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 Riboflavin lyase is a flavoenzyme which utilizes reduced flavin (FMN) (23) as 
the cofactor to cleave a second flavin molecule riboflavin (1). The enzyme first binds to 
reduced FMN (23) followed by riboflavin (1). Reduced FMN (23) at the active site then 
reacts with molecular oxygen (20) to give the corresponding flavin semiquinone (112) 
and superoxide radical anion (104). Superoxide radical anion (104) then abstracts a 
hydrogen from the C1' position of the substrate riboflavin generating the riboflavin-C1'-
radical (114) and hydrogen peroxide (113). 114 in the next step transfers an electron to 
the cofactor, FMN semiquinone (112) at the active site and is converted to the flavin-C1'-
imine (129). In the subsequent step, the hydrogen peroxide (113) at the active site 
combines with the imine (129) to produce the flavin-C1'-hydroperoxide (130). After this, 
the reduced cofactor FMN (23) at the active site reduces 130 to the corresponding flavin-
C1'-hydroxide (132). During this step, the reduced FMN (23) is converted to the 
oxidized FMN (2) via the formation of the flavin-4α-hydroxide (131). Flavin-C1'-
hydroxide (132) in the next step is hydrolyzed to generate lumichrome (12) and ribose 
(15).  
The generation of lumichrome (12) when riboflavin lyase is incubated with 
potassium superoxide (111) and riboflavin (1) provides direct evidence for the formation 
of the superoxide radical (104) as an intermediate in the enzymatic reaction. Analog 
studies with lumiflavin (86) indicated that the reaction indeed proceeds through a radical 
mechanism. To confirm the intermediacy of the riboflavin C1' radical (114) in the 
reaction mechanism, the radical trap cyclopropylmethylflavin (115) has been used. With 
cyclopropylmethylflavin (115) as the substrate, a ring cleavage chemistry due to β-bond 
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scission after the formation of the radical at C1' generated butanal (117) as one of the 
reaction products confirming the formation of the riboflavin C1'-radical (114). Absence 
of any release of hydrogen peroxide (113) by oxygen electrode experiments, followed by 
18
O incorporation experiments confirming the incorporation of oxygen atom into the 
ribose (15) from molecular oxygen (20) led to the proposal for the formation of the 
flavin-C1'-hydroperoxide (130) from its preceding imine (129). Finally the 
stoichiometric formation of lumichrome (12) with externally added reduced FMN (23) 
indicates that the oxidized FMN (2) is the final product of the reaction. From these 
results we propose that the reduced cofactor FMN (23) at the active site reduces 130 to 
the flavin-C1'-hydroxide (132) followed by hydrolysis to lumichrome (12) and ribose 
(15).  
9.2 Conclusion 
RcaE serves as the first example where the reduced cofactor FMN (23) is 
required to catalyze the breakdown of a second flavin molecule, riboflavin (1). This 
novel transformation is brought about by a flavin derived superoxide radical (104) 
system. Mixed function amine oxidase (MFAO) is the only reported example speculated 
to proceed via a similar flavin derived superoxide radical intermediate. Riboflavin lyase 
(RcaE) is the first example of a flavoenzyme where conclusive evidence for the actual 
participation of a superoxide radical is shown. The fact that a superoxide radical 
mediated enzymatic conversion of riboflavin (1) to lumichrome (12) is observed even in 
the absence of the reduced cofactor FMN (23) points to the fact that the superoxide 
radical (104) is the active oxidizing species in the transformation (Figure 78). The role of 
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the cofactor, reduced FMN (23) is the generation of this superoxide radical (104) from 
oxygen (20).  
Figure 79: Scheme for hydrogen abstraction from the substrate by flavin derived superoxide 
radical (104) to give the substrate radical. 
9.3 Future Perspective 
Further degradation of the isoalloxazine ring 
In the Microbacterium marytipicum G10 strain isolated from a riboflavin rich 
environment, lumichrome is not further degraded and is precipitated out into the 
medium. This interesting observation indicates that the purpose of riboflavin degradation 
in this strain and some other rhizobia (as evident from the phylogenetic distribution of 
RcaE) is the production of the alloxazine ring, lumichrome (2) which can then act as an 
important signaling molecule. Hence, the catabolism stops at this stage. 
In contrast, there might be other strains present in riboflavin rich environment 
which may be able to cleave the alloxazine ring of the flavin all the way to use this 
molecule as a potential carbon and/or nitrogen source. Such an example was reported by 
the Stadtman group in 1965 where a Pseudomonas RF strain was shown to degrade 
riboflavin all the way to the lactone (18) and oxalimide (19) (Figure 4).
28,31
 But the strain
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could not be recovered for further studies. The future goal of the riboflavin catabolism 
project will be to focus on the isoalloxazine catabolism. The group of bacterial strains 
that have been collected from DSM Nutritional Products, Germany, might contain an 
individual strains responsible for isoalloxazine catabolism. The soil and dust samples 
recovered from DSM will be grown on riboflavin using an enrichment method to 
identify the strains growing on riboflavin as the carbon/nitrogen source. This will be 
followed by isolation of the individual strains that can grow on riboflavin. 
Crystal structure determination with the cofactor and the substrate/product bound 
A crystal structure of the enzyme will throw light on the active site 
conformations of the enzyme and the binding pockets for the two flavins along with 
molecular oxygen. We have obtained protein crystals for an ortholog of riboflavin lyase 
from Herbiconiux species at 2.1 Å resolution with the cofactor 5-deazaFMN (72) bound. 
The insolubility of the substrate riboflavin (1) in aqueous medium might play a role in its 
inability to co-crystallize with the protein. Currently we are working on obtaining a 
RcaE orthologs crystal bound to both the cofactor 5-deazaFMN (72) and a relatively 
water-soluble substrate analog such as 6,7-dimethyl-8-ribityllumazine (136) (Appendix 
A) to get a deeper insight into the active site structure. This may also help to identify the
oxyanion hole responsible for binding to molecular oxygen and also the superoxide 
radical intermediate.  
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Appendix A: Structures of the analogs and their derivatives for flavin and the sugar chain 
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Appendix B: Reaction catalyzed by para-hydroxybenzoate hydroxylase 
 
 
 
 
 
 
 
Appendix C: Active flavin oxygenating species 
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Appendix D: Formation of the corresponding oximes for different flavin substrates after 
treatment with PFBHA 
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Appendix E: Synthesis of 5-deazaFMN (72) and 5-deazariboflavin (73) from 5-deazaFAD (71) 
 
 
 
 
 
Appendix F: Scheme for the synthesis of 2'-deoxyriboflavin (84) and its NMR characterization 
 145 
 
 
Appendix G: Scheme for the chemical degradation of riboflavin (1) with potassium superoxide 
(111) 
 
 
 
 
Appendix H: Whole protein mass spectroscopy of RcaE as is and RcaE after reaction with 
cyclopropylflavin (115). No change in mass is observed 
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Appendix I: Cyclopropylmethylene-dansylhydrazone 80 not detected in the reaction of RcaE 
with cyclopropylmethylflavin (115).  
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Appendix J: Scheme for the synthesis of 3 : 1 (R : S) 1'-D-riboflavin (84) and its LCMS 
characterization 
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Appendix K: Scheme for the synthesis of 1 : 3 (R : S) 1'-D-riboflavin (84) and its LCMS 
characterization 
 
 
